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Abstract 
Tendons and ligaments are structures that are present through the human body and 
when damaged, may present considerable complications. Due to their low scarring 
ability, especially in intraarticular tissues, surgery is frequently required. Surgery 
that consists in suturing both ends of the injured tissue is ineffective due to the low-
quality scarring and the low mechanical properties exhibited by the tissue 
afterwards. Due to this, autograft techniques are the most common route in tissue 
repairing surgeries. Despite showing good results, this technique also reveals some 
disadvantages.  
Tissue engineering scaffolds may aid in overcoming these limitations. They consist in 
an artificial biodegradable ligament or tendon which is implanted in the site of the 
damaged tissue and promotes tissue growth while it degrades, besides providing 
mechanical support. Ideally, a tendinous or ligamentous tissue takes its place 
afterwards. However, designing a scaffold is complex as it must meet some 
requirements such as being biocompatible, promoting tissue growth, displaying a 
mechanical behaviour similar to the tissue which is being repaired and more. 
The goal of this investigation was to design a scaffold for the regeneration of the 
Achilles tendon, possessing appropriate chemical composition and mechanical 
properties during degradation. The design of two types of scaffolds using a simplified 
model was performed. One fully degradable, and one semi-degradable scaffold were 
designed utilizing polymers which were already employed in biomedical applications, 
such as PLGA, PLA, PCL, PDS and PTFE. A structure composed by parallel fibres only 
and exhibiting a linear elastic behaviour was assumed for the scaffold. To analyse 
the mechanical behaviour of the scaffold during the regeneration of the tendon, 
simulations were performed in a spreadsheet. All the data utilized in the design and 
simulations were gathered from the literature. 
In the simulations, the scaffolds exhibited adequate mechanical behaviour during 
degradation, losing its properties gradually and preventing the regenerating tissue 
from rupturing. Therefore, the scaffolds have shown, in this preliminary study, that 
they could perform well at values of constant strain or stress associated with normal 
locomotion in the Achilles tendon. 
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Resumo 
Os ligamentos e tendões são estruturas que estão presentes por todo o corpo humano 
e várias vezes são danificadas. Devido à sua baixa capacidade de cicatrização, 
principalmente em tecidos intra-articulares, a cirurgia é necessária. A cirurgia que 
consiste na sutura do tendão ou ligamento é ineficaz, devido à cicatrização de baixa 
qualidade e baixas propriedades mecânicas apresentadas pelo tecido. Devido a isto, 
a técnica de autoenxerto é a via mais utilizada em cirurgias de reparação de tecidos. 
Apesar de apresentar bons resultados, esta técnica também apresenta desvantagens.  
O uso de dispositivos biodegradáveis sintéticos pode ajudar a ultrapassar estas 
desvantagens. O scaffold consiste em um ligamento ou tendão artificial 
biodegradável que é implantado no local do tecido danificado e promove o 
crescimento do tecido enquanto este se degrada, para além de fornecer suporte 
mecânico. Idealmente, depois da sua degradação, um tecido ligamentoso ou 
tendinoso toma o seu lugar. Porém, projetar este dispositivo é complexo pois tem 
que preencher vários requisitos, como ser biocompatível, promover o crescimento 
do tecido, apresentar um comportamento mecânico adequado, entre outros.  
O objetivo deste trabalho foi realizar o design de um scaffold para o tendão de 
Aquiles, com uma composição e comportamento mecânico adequado a promover a 
regeneração do tendão. Utilizando um modelo simples, foi realizado o design de dois 
tipos de scaffolds, um totalmente absorvível, e um semi-absorvível utilizando 
materiais já utilizados em aplicações biomédicas, como PLGA, PLA, PCL, PDS e PTFE. 
Para o scaffold, assumiu-se uma estrutura composta apenas por fibras paralelas, 
apresentando um comportamento elástico linear. De forma a avaliar o 
comportamento mecânico durante a regeneração do tendão, realizaram-se 
simulações numa folha de cálculo. Os dados utilizados neste trabalho foram obtidos 
através duma análise da literatura. 
Nas simulações, os scaffolds apresentaram um comportamento mecânico adequado 
à função, perdendo as propriedades gradualmente e prevenindo a rotura do tecido 
que se está a regenerar. Os scaffolds demonstraram então, neste estudo preliminar, 
que são capazes de cumprir o seu objetivo enquanto sujeitos a valores de deformação 
e tensão constantes associados à locomoção normal no tendão de Aquiles. 
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Motivations and Objectives 
Ligaments and tendons have a fundamental role in allowing in the human body 
keeping bones and muscles together, primarily contributing to the transmission of 
forces and the stabilization of joints. When these tissues are injured, it has a great 
impact on the normal function of joints and leading to instability and pain. Injuries 
in tendons and ligaments also have other major concerns such as their low-quality 
healing and low healing rates. Some solutions for the repair of these tissues are 
employed, however several limitations presented by these techniques motivate the 
research for better solutions in the field of tissue repair. Tissue engineering scaffolds 
seem a promising approach in tissue repair, however, an optimal solution was not 
yet found.  
In order to further study scaffolds used in the repair of the Achilles tendon, this study 
focused on determining a chemical composition for the scaffolds and studying its 
mechanical behaviour during the degradation of the scaffold and regeneration of the 
Achilles tendon tissue, the load transference from the scaffold to the tissue and 
whether the scaffold could provide an appropriate mechanical support to the tissue 
during its regeneration preventing it from rupturing in the earlier stages. 
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1. Introduction 
Ligaments and tendons are an essential part of the musculoskeletal system, primarily 
contributing to the transmission of forces and the stabilization of joints. Ligaments 
have two insertions, connecting bone to bone, while tendons have only one insertion, 
having the other joined with the muscle. Both are connective tissues, consisting in 
dense bands of collagen fibres, named fibrous connective tissue. They can vary in 
shape, orientation and size [1]. This makes performing simple and complex motions 
possible. Tendons aid in motion of the body by transmitting force from the muscle 
to the bone. These tissues have high mechanical strength under tensile loads and are 
resistant to cyclic efforts that are executed during the daily activity of the 
musculoskeletal system as they work as elastic energy absorbers [2, 3]. Knowing this, 
damaging these tissues has a great impact in normal biomechanical function 
impairing the function of joints and may lead to the degeneration of joints and 
abnormal wear, as well as instability and pain. Injuries in ligaments and tendons are 
very common, especially for people involved in sports activities and elderly people. 
There are many areas throughout the body where these tissues can experience such 
injuries, like knees, hips, shoulders, ankles, elbows and wrists [3-5]. 
The incidence of tendon injuries has increased substantially in the last decades, 
particularly in athletes. The number of Achilles tendon injuries heavily influences 
this increase in tendon problems. Due to its limited blood supply, an injured Achilles 
tendon, especially in ruptures, heals slowly. This limited healing capacity 
complicates the treatment for this tissue. Spontaneous healing may happen, but it 
generally results in the formation of scar tissue which possesses low mechanical 
properties. Surgically, the simplest solution is the suturing of both ends of the 
tendon. Another approach used is the implantation of allo- or autografts. These yield 
better results than the suture surgery, but still exhibit disadvantages such as donor 
site morbidity, limited availability, disease transmission and tissue rejection [6, 7]. 
Along with these options, the use of synthetic non-degradable ligament replacements 
was also employed, such as the Gore-Tex® artificial ligament and the Dacron 
ligament. However, they revealed poor long-term results [8]. 
Therefore, tissue engineering represents a more promising approach as it combines 
knowledge and strategies from material science, molecular biology, medicine and 
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engineering to enable full tissue regeneration rather than replace the injured tissue 
with one partially functionalized foreign substitute. Tissue engineering generally 
includes a porous, three-dimensional, biodegradable scaffold which behaves as a 
temporary support that enables tissue growth. This structure enhances tissue growth 
by aiding in cell proliferation, promoting matrix production and organizing the matrix 
into functional tissues. Additionally, there are scaffold enhancing approaches which 
increase the scaffold’s performance and further promote tissue growth. These 
approaches include cellular hybridization, surface modification, use of growth 
factors and mechanical stimulation [7, 9]. 
The porous scaffold must be biodegradable, biocompatible, have the appropriate 
mechanical properties for the applications, the architecture should be optimal, 
providing enough area for cell attachment, and proliferation and the degradation 
rate must be suitable, in order for when the tissue is healed, the scaffold be 
completely degraded [10]. To this day, many materials have been investigated for 
use in scaffolds for tissue engineering. These include synthetic polymers 
(polyurethane, polylactic acid, polyglycolic acid, polycaprolactone, 
polyhydroxyalkanoates and alginates), fibrin, hydrogels, silk and other biological 
materials [11].  
2. Tendons and Ligaments 
2.1. Ligament and Tendon Structure 
While ligaments and tendons appear as a single structure, they are in fact a complex 
system composed by smaller components. Both tendons and ligaments have a very 
similar structure. The main cell type present in these tissues are fibroblasts. 
Fibroblasts present in tendons are elongated and are named tenoblasts. These are 
immature tendon cells which will give rise to tenocytes. Tenocytes are terminally 
differentiated tendon cells with limited proliferative capacity and are attached to 
collagen fibres throughout the tissue. They are connected to the ECM (Extracellular 
matrix) by integrins that allow cell to sense and respond to mechanical stimuli. These 
integrins are transmembrane receptors that enable cell-ECM adhesion. These cells 
secrete a precursor of collagen, named procollagen, which is then cleaved into 
collagen fibres. Fibroblasts only represent a small portion of the tissue. Water 
constitutes most of the tissue’s composition (70% wet weight), being responsible for 
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cellular function and viscoelastic behaviour. For the solid components, collagen type 
I is the main component, representing 65-80% of the dry mass. This type of collagen 
constitutes 95% of the collagen content, with the remaining 5% being collagen types 
III, VI, XI and XIV). Other constituents comprise the remaining percentage such as 
elastin, actin, laminin and proteoglycans which are responsible for storing water, 
bridging the gap between neighbouring fibres and providing shear resistance [1, 12].  
Table 1 - Biochemical constitution of tendon (wet weight) 
Tissue 
type (wet 
weight) 
Water (%) Collagen 
(%) 
Collagen 
type I (%) 
Other 
types of 
collagen 
(%) 
Other 
components 
(%) 
Ref. 
Tendon 70 20-24 19-23 1 6-10 [10,11] 
 
The tendon has a hierarchical structure with different levels of organization including 
collagen molecules, fibrils, fibres, and fascicles which are parallel to the long axis 
of the tissue. In Figure 1 these components are illustrated. Tendinous and 
ligamentous structures are very similar but have some differences. Tendons have less 
percentage of proteoglycans in their structure, and they have slightly more 
percentage of collagen fibrils and more organized [1]. Microscopically, it is possible 
to observe that ligaments and tendons display a “waviness” in their structure that 
explains their mechanical behaviour, this characteristic of the structure is called 
“crimp”. The angle and length of the crimp pattern varies on whether it is a tendon 
or a ligament, its anatomical site and its location in the tissue. Looking at the 
mechanical behaviour of these tissues, it is possible to understand that this crimp 
has a major role on the non-linear viscoelastic behaviour [13, 14]. 
 
Figure 1 - Hierarchical structure of tendons (adapted from [15]) 
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Figure 2 - Example of stress relaxation at constant deformation (adapted from[1]) 
2.2. General overview of the mechanical behaviour of tendons and ligaments 
Soft tissues like ligaments and tendons display a time-dependent behaviour. This 
means that the relationship between stress and strain is not constant but rather 
depends on the time displacement or load. This behaviour can be observed when the 
tissue is under cyclic loading. There are three major characteristics of a viscoelastic 
material: Creep, stress relaxation and hysteresis. An example of the viscoelastic, or 
time-dependent behaviour of tissues, is when the tissue is held at a constant strain 
level, the stress in the tissue decreases with time. This phenomenon is known as 
stress relaxation (Figure 2) [1, 16].  
 
 
 
 
 
 
 
 
 
Also, if the tissue is held at a constant stress level, the strain in the tissue increases 
with time, which is known as creep (Figure 3). Creep does not take place in normal 
elastic materials since the material, under a constant load, does not elongate 
independently of how long the load is applied. This behaviour is thought to be a 
function of the main component, collagen as well as the other components such as 
proteoglycans, glycoproteins, elastin and water. Another characteristic of the 
behaviour of these tissues is hysteresis or energy dissipation. When a viscoelastic 
material is loaded and unloaded, the loading curve is different than the unloading 
curve, as can be seen in Figure 4. This is called hysteresis. The difference between 
the two curves forms a hysteresis loop and represents the amount of energy 
dissipated during loading. This energy is lost as heat [1]. 
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Figure 3 - Example of creep at constant stress (adapted from [1]) 
Figure 4 - Example of Hysteresis (adapted from [1]) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
These viscoelastic behaviours for tendons and ligaments are essential for securing 
the motion and activity of the human body preventing fatigue failure of those tissues. 
For example, during walking or jogging, cyclic stress relaxation occurs, in which the 
maximum stress in the tissue decreases with each cycle [17].  
To describe the viscoelastic behaviour of ligaments and tendons mathematical 
models have been made. Many have been used but the most commonly used model 
in biomechanics literature is the QLV (quasi-linear viscoelastic) theory. It was 
modified and adopted to describe the viscoelastic properties of ligaments and 
tendons. This theory was used to join the nonlinearity (dependence of properties on 
load or strain) and time dependence (viscoelasticity) in a simplified integral model. 
In this model the stress-strain response is described as a separable function consisting 
of a stress or strain dependent function (independent of time) and a time dependent 
Hysteresis loop 
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Figure 5 – Illustration of a ligament or tendon stress-strain curve (adapted from [1]) 
relaxation or creep function (independent of stress or strain). Although, the QLV 
theory was frequently used to describe viscoelastic behaviour, only few studies have 
used it to predict the overall stress-strain response of ligaments and tendons. This is 
due to the limited ability of the QLV theory to predict the stresses and strains in 
response to loading conditions other than those used to fit the model. The accuracy 
of the model is lower at high levels of strain [17, 18]. Funk et al.  used the QLV to 
model the behaviour of foot ligaments and it was adequately modelled until 15% 
strain [19]. Another limitation of the QLV theory is that it cannot account for creep 
and relaxation rate dependency and cannot interrelate creep and relaxation [17, 18].   
Ligaments display a triphasic behaviour when exposed to strain, as shown in Figure 
5. First, there is a region where the tissue presents low amount of stress per unit 
strain, called non-linear or toe region. In this stage, the force is transferred to the 
collagen fibrils resulting in the straightening of the crimp pattern. This “uncrimping” 
presents a lower resistance than when the force is applied to stretch the collagen 
molecules in the second region, which explains why this region of the stress-strain 
curve shows relatively low stiffness. As the collagen fibrils become uncrimped, the 
collagen fibril backbone begins to be being stretched itself, exhibiting a much stiffer 
behaviour. This can be observed in the second region of the stress-strain curve. In 
this linear region, the collagen triple helix is stretched and interfibrillar slippage 
occurs between crosslinks. In the last stage, the individual fibrils start failing by 
defibrillation, damage accumulates, and stiffness starts to decrease until the whole 
tissue fails and disrupts [1, 5].  
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2.3. The Achilles Tendon  
The Achilles tendon is the largest and strongest tendon in the human body. Due to 
its size and functional demands, the Achilles tendon is susceptible to acute and 
chronic injuries and is directly or indirectly implicated in many pathological 
conditions of the ankle or foot [20]. During walking, the tendon is subjected to peak 
forces of 2.2-2.7kN associated with elongations between 14.3-15.2mm [21]. 
Elastin and collagen are the main constituents of the extracellular matrix of the 
Achilles tendon, 2 and 70% of the dry weight, respectively. Tenocytes (specialized 
fibrocytes) and tenoblasts lie between collagen fibres along the long axis of the 
tendon and represent 90-95% of the cellular elements of the tendon, and 
chondrocytes, vascular cells, synovial cells and smooth muscle cells constitute the 
remaining 5-10% [22, 23]. The collagen fibres are packed in parallel bundles which 
contain nerve, blood and lymphatic vessels, forming fascicles. The fascicles are 
surrounded by endotenon, which is a fine layer of connective tissue and grouped 
together, they form the macroscopic tendon. The tendon is surrounded by the 
epitenon, which is surrounded by the paratenon. These two are separated by a thin 
layer of fluid that reduces friction during motion [22]. 
Although the normal Achilles tendon consists almost entirely of type-I collagen, a 
ruptured Achilles tendon contains a substantial amount of type-III collagen [24]. This 
is due to the tenocytes that are present in the ruptured Achilles tendon produce 
more type-III collagen that tenocytes from a normal tendon. As type-III collagen is 
less resistant to tensile forces, consequently, the mechanical properties of the 
tendon decrease as well. The healthy Achilles tendon also presents a well-organized 
cellular arrangement, while the injured Achilles tendon does not [23]. 
For the regeneration of the tendon, the process occurs in three stages. In the 
inflammatory phase, erythrocytes and inflammatory cells, such as neutrophils, arrive 
at the site of the injury. In the first twenty-four hours, macrophages and monocytes 
predominate and phagocytosis of necrotic materials takes place. Chemotactic factors 
such as vasodilators and proinflammatory molecules that attract inflammatory cells 
from surrounding tissue are released.  Tenocytes start migrating to the injury site 
and collagen type-III synthesis begins [25]. In the proliferative phase, the recruitment 
of tenocytes and its rapid proliferation continues, and the synthesis of proteoglycans, 
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collagen, especially collagen type-III, and other constituents of the ECM peaks. 
Initially, these components are arranged in a random manner within the ECM. In the 
end of this phase, the tissue is highly cellular [7]. After six to eight weeks, the 
remodelling phase begins, and there is a decrease in cellularity, matrix synthesis and 
collagen type-III as opposed to the type-I collagen synthesis which increases. This 
phase can be divided into a consolidation and maturation stage. In the first stage the 
tissue changes from cellular to fibrous. Tenocyte metabolism remains high and type-
I collagen fibres become organized along the tendon axis and are responsible for the 
mechanical strength of the tissue. As the mechanical properties of the tissue 
increase, the callus transverse area gradually decreases. However, the tissue 
remains hypercellular and with high amounts of type-III collagen which has less 
potential for cross-linking the fibres than type-I collagen, and the collagen fibrils 
become thinner, leading to inferior mechanical properties when compared to the 
uninjured tendon. This is represented in Figure 6. After ten weeks, the maturation 
stage begins, and interaction between collagen structural units lead to higher tendon 
stiffness and tensile strength and the fibrous tissue gradually changes to scar-like 
tissue over the course of one year [7, 25].  
 
Figure 6 - Representation of the recovery of properties in healing tendons (adapted from [6]) 
2.4. Current treatment and rehabilitation procedure for Achilles tendon rupture 
Achilles tendon ruptures are common, but the treatment of acute ruptures in the 
Achilles tendon is a topic which is considerably debated as there is no standard 
protocol for the treatment [26]. The treatment options for the Achilles tendon 
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rupture include nonsurgical and surgical procedure. In the case of a nonsurgical 
procedure, a cast-boot will be used with the foot placed in plantar flexion, and early 
physiotherapy can be performed. As for the surgical procedure these include slightly 
invasive, open and percutaneous repair of the tendon. Advocates for the nonsurgical 
treatment defend that by keeping the foot in plantar flexion is enough to achieve 
healing of the injured tendon. In theory, this healing is achieved without the risks 
inherent to the surgical procedure. However, Achilles tendon repair surgery is 
performed due to higher rerupture rates being associated with the nonsurgical 
treatment. In the meta-analysis conducted by Soroceanu et al., it was suggested that 
the rerupture rate of both treatments were equivalent [27].  
Whether surgical or nonsurgical treatment is applied, they are followed by a 
rehabilitation period in which the ankle is casted or braced for 6 to 8 weeks. The 
rehabilitation can involve either immobilization or early mobilization. 
Immobilization achieves tendon healing by haematoma formation, collagen 
proliferation and then collagen maturation. However, this method is associated with 
joint stiffness, muscle atrophy tendocutaneous adhesions [28]. 
Wolff’s law and Davis’ law are two major physiological principles in the field of 
physical rehabilitation, that support early mobilization. They state that bone 
(Wolff’s Law) and soft tissues (Davis’ Law) regenerate according to the manner that 
they are stressed. Davis’ Law states that the healing soft tissue responds to stress by 
reacting along the lines of the given stress. For optimum healing, the tissue should 
be gradually stressed in order to accept a given force. If the healing tissue is not 
stressed in the manner required of it previously, the tissue will not be prepared to 
fully accept preinjury requirements. However, if the regenerating tissue accepts this 
stress during healing, it will lead to the strengthening of the tissue [29]. Following 
Davis’ Law, the “stretch-hypertrophy rule”, from Frost, states that "Intermittent 
stretch causes collagenous tissues to hypertrophy until the resulting increase in 
strength reduces elongation in tension to some minimum level" [30].  
The positive effects of the mechanical load on the remodelling of tendons have been 
observed [31]. Other studies reported that cyclic tensile loading promotes the 
collagen fibres to align parallel to the longitudinal axis of the tendon, which inhibits 
adhesions around the tendon and increases tendon strength, vascularity and number 
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of collagen fibres [28, 32]. Nöth et al. demonstrated that mechanical stimulation 
increases collagen production by applying cyclic stretching for 8h per day to a 
collagen type I matrix. An increase of gene expression of collagen type I and III, 
fibronectin and elastic in the stretched constructs was observed when compared to 
the non-stimulated constructs [33].  
3. Scaffolds for ligament and tendon regeneration  
3.1 Fundaments and requirements  
Many tissues in the body are capable of self-healing after injury, but other such as 
ligaments and tendons have limited regeneration. For this, tissue engineering offers 
alternative methods to restore tissues and its functions. Scaffolding in tissue 
engineering consists on the use of a scaffold as a structural support and providing a 
microenvironment which enables cell attachment, proliferation, and differentiation, 
in order to produce a functioning tissue to replace or repair a damaged tissue. For 
that reason, the physical structure, chemical composition and biological attributes 
are essential features in tissue engineering. These structures should partially mimic 
the ECM of the tissue which is to be regenerated [10, 11]. 
For application in tissue engineering, scaffolds have some basic requirements: 
• Architecture: they should have open porous interconnected networks for cell 
nutrition, proliferation, and migration, new tissue formation and 
vascularization. This porosity is essential but should not compromise 
mechanical properties [10, 34]; 
• Biocompatible: The scaffold should be biocompatible by not inducing any 
harmful, toxic or immunologic response. Also, it should promote cell 
attachment, growth and differentiation during both in vitro culture and in 
vivo implantation [10]; 
• Mechanical properties: Scaffold should provide mechanical and shape stability 
to tissue, without provoking stress-shielding. The intrinsic mechanical 
properties of the biomaterials used in the production of the scaffold should 
match the properties of the host tissue [23] 
• Surface area: The scaffold should provide enough surface area for cells to 
attach and proliferate [10]; 
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• Biodegradability: The scaffold should be biodegradable and degrade gradually 
to allow a controlled exposure of the neotissue to the local mechanical 
environment promoting a structure formation and function more similar to the 
native tissue. The degradation rate should approximately match the growth 
rate of the neotissue to avoid the stress shielding phenomenon and allowing 
room to the new tissue to grow [6]. 
For various applications inside tissue engineering, the primary materials for 
scaffolding are polymers. Synthetic polymers have advantages over natural polymers 
as they are more flexible, their behaviour is more predictable, and have better 
processability. Physical and chemical properties of these polymers can be easily 
modified so mechanical and degradation characteristics can be altered. Synthetic 
polymers such as PGA (Polyglycolic acid), PLA (Polylactic acid) and their copolymer 
PLGA (Poly (lactic-co-glycolic) acid) are aliphatic polyesters which are frequently 
used in tissue engineering. These polymers degrade through simple hydrolysis which 
is desirable as the degradation rates have low variations from host to host, except 
for cases where inflammations, implant degradation and other complications take 
place. These materials will be more deeply investigated further in this work [35, 36]. 
Naturally derived polymers have also been used in tissue engineering such collagen, 
glycosaminoglycan, alginic acid, chitosan, polypeptides, silk and more. Natural 
derived polymers often possess highly organized structures and may contain an 
extracellular substance called ligand, which can be bound to cell receptors. The 
great advantage of these materials is their biocompatibility however, they are 
limited by the lack of large quantities and difficulty in processing these materials 
into scaffolds [36, 37]  
One of the vital aspects in the use of a scaffold for tissue regeneration is its 
mechanical behaviour. The design of the scaffold must meet some requirements such 
as tensile strength, stiffness and absorption rates which must be appropriate to the 
injured tissue. The tensile strength of the tissue should be greater than in vivo peak 
loads supported by the tissue as a measure to ensure that the scaffold will not fail 
under normal conditions. The stiffness of the tendon should be adjusted to the tissue 
allowing load sharing across the repair site to promote optimal biologic repair and 
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providing reinforcement at the same time. Also, the scaffold should not stretch more 
than the toe region of the stress-strain curve [38]. 
3.2 Scaffold enhancing approaches 
Even though tissue engineering scaffolds have a great potential for tissue 
regeneration and enhancing its properties, many times the structure alone is not 
enough. Therefore, scaffold enhancing approaches are available.  
These include surface modification, growth factor and cell seeding in the scaffold 
matrix and mechanical stimulation. As said before, the scaffold must interact 
positively with cells to promote tissue growth. This positive interaction is achieved 
by creating a microenvironment favourable for cell differentiation and proliferation. 
The components which enable the creation of this microenvironment include the 
presence of growth factors, cell-cell interaction and cell-matrix adhesions [39]. Cell 
adhesion is essential to this process as cells need a substrate to adhere before 
differentiation and proliferation. However, synthetic polymers do not possess natural 
binding sites, therefore cell adhesion is mediated through plasma/serum proteins 
adsorbed into the polymer surface [40]. The parameters which are involved in cell 
adhesion are surface roughness, chemical composition, the electric charge effect, 
surface hydrophilicity or hydrophobicity and surface wettability [41]. Knowing this, 
it is fundamental to identify what are the options to increase the cell adhesion of a 
scaffold. Surface modification has shown great results in improving cell attachment. 
It is possible to modify a hydrophobic surface, chemically or physically, into a 
hydrophilic one manipulating its surface energy. Boland et al. reported an increase 
in the biocompatibility of PGA fibres through a pre-treatment using concentrated 
hydrochloric acid [42]. Yang et al. also modified the surface of PLLA (Poly L-lactic 
acid) and PGA scaffolds but using an anhydrous ammonia plasma treatment and the 
results showed an improvement in hydrophilicity and surface energy. Cell culture 
results suggested that the treatment increased cell affinity in the scaffolds [43]. In 
addition to surface modification, the use of nanofibrous scaffolds can also increase 
cell adhesion. This technique consists in producing a biomimetic structure that 
replicates the natural ECM to the nanometre scale. These scaffolds are formed by 
nanofibers with diameters close to the collagen fibres in the tendon to which cells 
attach and organize themselves around. These scaffolds have a higher surface area 
to volume ratio than microfibrous scaffolds [44]. Woo et al. reported that using a 
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nanofibrous architecture in a scaffold improves protein adsorption, and consequently 
cell interactions with scaffolds [45].  
In tissue engineering scaffold, cells seeding in the scaffold matrix in order to promote 
the repair of the damaged tissues is also performed. The introduction of cell in 
scaffold matrixes is known to increase tissue growth and its properties. Young et al. 
studied the effect of using MSC-seeded implants on the healing of a gap defect on 
the Achilles tendon of rabbits. Treated tissues showed substantial increase in 
mechanical properties, cross-section area and better collagen fibre alignment [46]. 
There are several types of cells which are used in tissue engineering. Studies are still 
being conducted trying to determine which is the best type of cell for use in tissue 
engineering [47, 48]. Tenocytes are one obvious option to use in tissue engineering 
constructs, since they are the primary cell-type in tendons. Cao et al. used a 
tenocyte seeded PGA scaffold to bridge tendon defects in hens. The tissue which 
resulted from the scaffold use resembled a natural tendon and were abundant in 
tenocytes and collagen. Its breaking strength was about 83 percent of a normal 
tendon at 14 weeks [49]. However, along with being short living and terminally 
differentiated, the use of tenocytes still has one major problem, which is the 
harvesting of autologous tenocytes. Tendons are hypocellular tissues, and the 
harvest of autologous tenocytes can cause donor site morbidity [9]. 
As an alternative to tenocytes, other cell types are being studied to promote tissue 
regeneration. These include human dermal fibroblasts [50], adipose derived stem 
cells [51], bone marrow-derived stem cells [46, 52, 53] and human embryonic stem 
cells [54]. Mesenchymal stem cells are multipotent stem cells that have the ability 
to differentiate into several types of cell depending on the environment. Using 
growth factors, it is possible to control the differentiation of the cell. These cells 
may be obtained from many sources including adipose tissue, bone marrow, muscle 
and umbilical cord [55]. As for the growth factors, these can be added to the culture 
or secreted by stem cells. They are soluble secreted signalling polypeptides which 
instruct specific cellular responses in a biological environment. These factors are 
signalling molecules that stimulate cell proliferation, and differentiation. Besides 
growth factors, mitogens and morphogens are also signalling molecules which aid in 
this process and by regulating these molecules, it is possible to allow control over 
the regenerative process. PDGF (platelet-derived growth factor), FGF (fibroblast 
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growth factor), TGF (transforming growth factor) are some example of growth 
factors employed in tissue engineering [56]. 
As it was referred in Section 2.4 mechanical stimulation is vital to the recovery of 
the tissues after injury. Mechanical stimulation modulates cell behaviour. Cyclic 
strain in in vitro conditions, has great effects on tenocyte functions such as their 
metabolism and the increase of the mechanical properties of the resulting tissue [57, 
58]. Various studies have also reported positive results on the mechanical stimulation 
of tissue engineering constructs [33, 59-61] 
3.3 Fibrous structures 
Scaffolds may be designed in different forms which include foams, sponges, 
hydrogels, meshes, fibres and more. The architecture of the scaffolds depends 
mainly on the properties of the material used and, on the purpose and function of 
the scaffold.  For tissue engineering, fibrous scaffolds present some advantages when 
compared to other types of scaffolds. These structures are fabricated using fibres or 
yarns of synthetic or natural polymers. Fibrous scaffolds also allow 3D (three-
dimensional) culture instead of 2D (two-dimensional). This supports a higher cell 
density than flat 2D surfaces. These scaffolds also present high porosity, isotropic 
structure and homogeneous fiber and consequently pore size [44].  
Parallel fibres are the simplest fibrous structure. However, the lack of interaction 
between the fibres narrows its application [62]. Fibrous structures are usually used 
in woven, nonwoven, knitted, braided and electrospun.  Each textile type has its 
physical and mechanical properties and the type of textile used will depend on the 
required properties of the application. Woven structures exhibit the highest strength 
value and are suitable for long term applications. Knitted structures, as opposed to 
woven, are anisotropic. The yarn changes directions continuously through the fabric. 
Also, the yarn density is lower than in woven textiles which increases structure 
porosity. They exhibit lower mechanical strength than woven structures, but the 
possibility of inserting holes in the structure enhances surface area and permeability 
which promotes tissue ingrowth. Braided structures consist in three or more yarns 
intertwined over each other. These structures have the highest axial strength 
compared to other textiles. Therefore, they are excellent for high in-plane 
mechanical strength. Due to their structure they can withstand high loads and 
15 
 
provide extension. Porosity and mechanical properties can be tuned by varying 
structural factors such as number of yarns, yarn angle relative to the vertical 
direction. Nonwoven structures were introduced in the 1990s and were used mostly 
under the name Ethisorb™. Nonwoven structures are more random than the previous. 
Due to this randomness, sometimes is necessary to strengthen the structure by 
bonding the fibres in the web [63]. More organized structures such as woven, braided 
and knitted scaffolds may provide an oriented growth for cells, which has great 
impact on cell behaviour [64, 65]. In studies found for Achilles tendon scaffolds, 
knitted structures were used the most. [62, 66-68]. This is mainly due to the high 
porosity, and consequently, high ability to support tissue ingrowth exhibited by 
knitted structures when compared to braided structures [62, 66] 
Eichhorn et al. demonstrated the relationship between the fibre diameter and pore 
size [69]. Nanofibrous scaffolds have many advantages compared do microfibrous 
scaffolds, such as more surface area to volume ratio and better mimicking of the 
ECM structure. However, the small diameter of these fibres reduces pore size and 
interconnectivity, thus provides a 2D environment for cell growth instead of 3D. This 
limits the cell attachment greatly, as cells cannot infiltrate the scaffold which limits 
cell proliferation [70]. Cells behave much differently in 2D and 3D matrixes. Pore 
size and high interconnectivity are very important for cell infiltration, cell 
interaction and nutrient and waste transport [71]. As an attempt to solve this issue, 
a scaffold with hybrid fibre size composed by nano- and microfibres was investigated 
[44]. This enables to get the cell attachment provided by the nanofibers with the 
structural support of the microfibres and bigger pores. Tuzlakoglu et al. studied 
these hybrid structures using type I collagen nanofibers and starch-based 
microfibres. The use of this combined structure increases the metabolic activity of 
the cells and cell growth [72]. However, limited cell migration is observed due to 
the nanofibers in these scaffolds [73]. 
Other methods are available to utilize the qualities of nanofibers without having the 
problem of having small pores. For example, Lee et al. suggested the use of micro-
voids in nanofibrous structures to improve cell migration [74]. In another study, 
Thorvaldsson et al. used electrospun nanofibers to coat single microfibres. Cellular 
infiltration and proliferation were observed along the coated microfibres of the 
scaffold, and which also maintained their surface and structural properties [75]. 
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Commercial synthetic fibrous scaffolds used in ligament and tendon tissue 
engineering include Gore-Tex®, Lars-Ligament®, Leeds-Keio®, and SportMesh™. The 
first four are non-absorbable scaffolds with the last being absorbable. All are 
approved by the FDA (Food and drug administration), except for the LARS ligament 
[63, 76, 77]. Gore-Tex® ligament is made of continuous multifilament yarns of tightly 
braided microporous PTFE (polytetrafluoroethylene). Its tensile strength is twice the 
human ACL and has higher stiffness. With this said, it was a very promising material. 
It was used worldwide between 1982 and 1990. Sterile synovitis, effusion and rupture 
were observed. Infection was also reported in 2-3% of the cases. Loosening of initially 
well-tensioned grafts was also reported, and localized inflammation originated by 
microbreakage and particle debris. Poor healing of the ligament was also observed. 
Initially, the implant presented good stability, which was deteriorated over time. It 
was removed of the market by the manufacturer by bad results (44% failure rate at 
5 years) [63]. 
LARS ligament is a second-generation, non-absorbable synthetic ligament composed 
by PET (polyethylene terephthalate) fibres. It has been approved by health 
authorities in Europe and Canada but not by the FDA for a wide range of applications 
such as ACL reconstruction, Achilles tendon repair and acromioclavicular repairs. It 
exhibited good results in the repair of collateral ligaments [78], posterior cruciate 
ligament [79] and anterior cruciate ligaments [80]. It exhibits good mechanical 
strength and biocompatibility to long term implantation [77].  
The Leeds-Keio graft is an artificial ligament, formed by PET fibres, especially 
designed to ACL reconstruction, hence its stiffness, 200N/mm, similar to the ACL 
[81]. Adverse results were reported regarding the use of this graft such as rerupture, 
synovitis and laxity were reported [82-84]. However, positive results also were 
reported [85, 86]. Leeds-Keio was also used for repairs of rotator cuff tear [87], 
Achilles tendon rupture [88], and ankle lateral ligament repair [89].  
Artelon® and SportMesh™ are made of biodegradable polyurethane urea (PUU), and 
it has been cleared in Europe and by the FDA for reinforcement of soft tissues such 
as rotator cuff, Achilles tendon, patellar, biceps and quadriceps. The Artelon® fibre 
is a slow degrading, biodegradable, with good mechanical properties which also 
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promotes cell ingrowth [90-92]. After 3 years of surgery, no adverse effects were 
reported and the results using Artelon® were better than in the control group [93].  
Table 2 – Commercially used synthetic fibrous grafts 
 
4. Biomaterials 
4.1 Biodegradable polymers 
Natural polymers such as collagen have been used in biomedical applications for 
many years, but the use of synthetic biodegradable polymers is relatively new, 
beginning in the 1960s. Since then, its use is growing greatly, being nowadays a field 
of much research. The rise of these materials is linked with their use in tissue 
engineering, regenerative medicine, gene therapy and bionanotechnology, all of 
which require biodegradable platform materials to build on. The biodegradable 
polymers have had tremendous success over the years, but great challenges remain 
in the design of biomaterials [94].  
In designing biodegradable biomaterials, many important characteristics must be 
considered. They must not evoke a sustained inflammatory response, possess a 
degradation time coincident with their function, have the appropriate mechanical 
properties for the application, the products of the degradation must be non-toxic 
and need to be available to be readily resorbed or excreted and present the 
appropriate permeability and processability. These characteristics are a result of 
Product Material Absorbable/Non-
absorbable 
Structure Function Company Ref. 
Gore-Tex® PTFE Non-absorbable Braided ACL WL Gore and 
Associates, 
USA 
[8, 77] 
LARS-
Ligament® 
PET  Non-absorbable Parallel 
longitudinal 
fibres 
(intraarticular 
portion) 
ACL Ligament 
Augmentatio
n and 
Reconstructi
on System, 
Dijon, France  
[8, 77] 
Leeds-
Keio® 
PET Non-absorbable Woven  ACL Xiros plc, 
Neoligaments
, Leeds, UK 
Yufu Itonaga 
Co. Ltd, 
Tokyo, Japan 
[8, 77] 
SportMesh™ 
/Artelon® 
PUU Absorbable Woven Rotator 
cuff, 
Achilles 
Tendon 
Artimplant [63] 
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many properties of the degradable polymeric biomaterials such as material 
chemistry, molecular weight, hydrophobicity, water adsorption, degradation and 
erosion mechanism [95].  
4.2 Degradation of Biodegradable polymers 
The difference between biodegradable polymers and regular polymers is their 
degradation, which is a valuable characteristic in biomedical applications. This 
means, it is important to study the degradation of these materials and its 
mechanisms. The biodegradability of a polymer mainly depends on its backbone 
structure. They depend on repetitive unit, composition, sequence length, molecular 
geometry, molecular weight, morphology, hydrophilicity, surface area and additives 
[96]. Biodegradable polymers can be degraded hydrolytically, enzymatically or both. 
Normally, natural polymers undergo mostly enzymatic degradation. However, the 
rate of in vivo degradation depends varies largely on the implantation site. Synthetic 
biodegradable polymers, on the other hand, degrade mostly by hydrolysis. These are 
preferred to be used in implants due to minimal site-to-site and patient-to-patient 
variations, when compared to enzymatically degradable polymers. Hydrolytically 
degradable polymers are polymers that have less stable chemical bonds in their 
backbone. This means their functional groups are susceptible to hydrolysis, and these 
can be: esters, ortho esters, anhydrides, carbonates, amides, urethanes and more 
[96, 97].  
Usually, there are two main possibilities to synthetize hydrolytically degradable 
polymers, it can be through step polymerization or addition polymerization, 
including ROP (Ring opening polymerization). Step polymerization is used to produce 
polyanhydrides, poly(ortho esters) and polyurethanes. ROP is used to develop 
hydrolytically sensitive polymers as poly(α-esters) and polyphosphazenes. Poly(α-
ester) can also be synthetized through bacterial bioprocesses [94].  
4.2.1 Polymeric degradation by hydrolysis 
Hydrolytically degradable polymers are polymers that have unstable chemical bonds 
that can break through the interaction with water. When the bond is broken, it yields 
two species with one gaining a hydrogen ion (H+) and the other gaining a hydroxyl 
group (HO-). Ester bonds are an example of these hydrolytically unstable bonds. 
These reactions depend on pH can be catalysed by acids, bases and enzymes [95]. 
19 
 
This chain scission process reduces chain entanglement rapidly, and subsequently, 
reduces strength [98].  
After immersion of the polymer in the aqueous medium, the first event that occurs 
is water uptake, and it continues until saturation. The maximum water uptake of a 
polymer depends on its hydrophilicity, crystallinity, temperature, pH and flow of the 
media. This leads to swelling, or, increase in volume. At this point, water molecules 
are in the polymer structure and start triggering the degradation of the polymer by 
cleavage of the polymer chains [99].  
There are two characteristics that are very important for the use of these materials 
in biomedical applications: degradation rate and the erosion mechanism. The 
degradation rate can vary considerably, from very unstable polymers 
(polyphosphazenes) to stable polymers (polyamides). An extremely important 
feature of these polymers is the ability to modulate the degradation rate of the 
material through the chemistry, conveying a significant flexibility on the properties 
of the material [95].  
The degradation of a polymer depends of factors such as water diffusion, solubility 
of the monomers, geometry, dimension of the implant, molecular weight, glass 
transition temperature (Tg) and hydrophobicity. Hydrophobicity is intimately 
connected with the ability of the polymer to absorb water. Hydrophilic polymers 
absorb substantially more water than hydrophobic polymers. The morphology of the 
material also influences the degradation rate, with greater crystallinity implicating 
less hydrolysis reaction and porosity being directly proportional to hydrolysis [95, 
98]. Among the characteristics of the material, biodegradation also depends on 
extrinsic factors. These factors include: pH of the degradation media, type of 
electrolytes present in the degradation media, the external stress/strain applied on 
the material, temperature of the degradation media, free radicals, enzymes, 
bacteria, lipids, synovial fluid and if the material was exposed to γ-radiation [100].  
Determining the type of erosion that takes place in the degradation of a polymer is 
essential as it is directly related to its application. It can be through surface erosion 
or bulk erosion. Surface erosion happens when the degradation rate at the interface 
water-polymer is much higher than the rate of the water diffusion to the bulk of the 
material. This results on a degradation that takes place mostly on the surface, with 
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the core remaining intact (retaining average molecular weight and mechanical 
properties). The load bearing capability decreases steadily until the thickness of the 
polymer reaches the critical thickness. When this happens, the erosion process shifts 
from surface to bulk erosion, where the time to failure is controlled by the auto-
acceleration of the hydrolysis. In this phase, the Mw (weight-average molecular 
weight) reaches its critical value, where the polymer depolymerises into water 
soluble products [98]. Polymers which degrade through surface erosion are 
particularly indicated for drug delivery applications [101]. Bulk erosion is 
characterized by the opposite situation, where the water diffusion rate is greater 
than the degradation rate on the surface, resulting on degradation throughout the 
material. PGA and PLA are two examples of polymers which undergo bulk erosion. In 
this erosion process, a decrease in molecular weight is seen before mass loss is 
observed [98]. The representation for the bulk and surface erosion processes and 
their influence on properties is shown in Figure 7.  
 
Figure 7 - Surface and bulk degradation and their effects (adapted from [98]) 
4.2.2 Enzymatic degradation 
 
Exposing polymeric biomaterials to bodily fluids and tissues can result in a 
degradation process of the polymer due to enzymatic activity. When the body reacts, 
and starts an inflammatory response to the material, the cells which are responsible 
of defending the organism, mainly leukocytes and macrophages, release extremely 
reactive specimens such as superoxides (O2-), hydrogen peroxide (H2O2), nitric oxide 
(NO), and hypochlorous acid (HClO). The oxidative effect of these specimens can 
contribute to the cleaving of polymer chains and their degradation [102]. Lee et al. 
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studied the oxidative effect of superoxides in absorbable sutures, and it was 
concluded that these specimens accelerate the process of degradation of the sutures 
and affect mechanical and thermal properties along with surface morphology. The 
amounts of tensile breaking force loss during the first 24h ranged from 3% to 80% 
depending on the absorbable suture [100].  
Hydrolysis can also be catalysed by enzymes such as proteases, esterases, lipases 
glycosidases and phosphatases. These enzymes are responsible for many reactions 
that happen in the human body [103]. The effect of lipases in the degradation of PCL 
was studied [104]. It showed that PCL (polycaprolactone) is sensible to the presence 
of pseudomonas lipase. However, the presence of PP lipase (porcine pancreatic) and 
candida cylindracea lipase did not have the same effect. This fact can help explain 
the fact of why the degradation rates in vivo are higher than in in vitro tests.  
In semi-crystalline polymers, when the degradation takes place due to enzymatic 
activity and hydrolysis, the process occurs in two phases. Firstly, water diffuses into 
the polymer and attacks the chemical bonds, preferably in the amorphous region, 
breaking longer polymeric chains into short chains, until there are only fragments 
soluble in water. As this happens first in the amorphous region, there is loss of 
molecular weight without decreasing mechanical properties as it is the crystalline 
region that holds the matrix. After, the degradation begins heavily on the crystalline 
region which result on the loss of mechanical properties. On the second phase, the 
enzymatic attack to the fragments generated in the process takes place. This 
metabolization results on fast loss of polymer mass [102].  
4.3 Aliphatic polyesters 
Aliphatic polyesters (or Poly(α-ester)s) are thermoplastic polymers which are greatly 
used as biomaterials due to their hydrolytically labile aliphatic ester bonds in their 
backbone and the products of the hydrolysis reaction are naturally metabolized by 
the human body. Theoretically, all polyesters are degradable as esterification 
(reaction between, usually, an acid and an alcohol, to from ester as the reaction 
product) is a chemically reversible process, but only poly(α-ester)s with short 
aliphatic chains between ester bonds can degrade over the time frame required to 
most biomedical applications. Polyesters can be synthetized from a variety of 
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monomers via ring opening polymerization and condensation polymerization routes 
depending on the monomeric routes [105].  
4.3.1 Polylactic acid (PLA) 
Lactide is a chiral molecule and can exist in two forms: D-Lactide, L-lactide. These 
can form PDLA (Poly-D-lactic acid) and PLLA respectively. The polymerization of 
these monomers will result in the formation of semicrystalline polymers. The 
polymerization of D, L-lactide and mesolactide will result in amorphous polymers. 
Among these monomers, L-lactide is the naturally obtaining isomer. It is a semi-
crystalline polymer with around 37% crystallinity, with this being a result of the 
molecular weight and processing parameters. The glass transition temperature is 
between 60-65ºC and the melting temperature is approximately of 175ºC. Compared 
to PGA, PLLA is a slow-degrading polymer, with lower tensile strength and good 
extension. Due to these properties, PLLA has been largely investigated as a 
scaffolding material for ligament replacement [94]. It is approved by the FDA for use 
in the human body [106]. Polylactides undergo hydrolytic degradation via bulk 
erosion, by the scission of the ester backbone. The degradation of the polymer 
results in lactic acid, a normal human metabolic by-product, which is broken down 
into water and carbon dioxide. Being more hydrophobic than PGA, this polymers 
degradation is much lower. However, the degradation depends on crystallinity and 
porosity of the matrix.  It has been reported that high molecular weight PLLA can 
take more than 5 years for total resorption in vivo [107]. PLA also undergoes 
enzymatic degradation when in low crystallinity polymers. Proteinase K degrades 
preferably L-L bonds, followed by D-L bonds and finally D-D bonds [108, 109]. Due to 
its semi-crystallinity PLLA is preferred over PDLLA (Poly-D, L-lactic acid) in 
applications where high tensile strength and toughness are required.  It is known that 
the polymer loses its mechanical properties due to hydrolysis after approximately 6 
months, but no significantly changes in the mass occurs for a long time. PLLA is used 
in FixSorb®, as a bone fixator [110] and in tissue engineering for bone [111], vascular 
[112], cartilage [113] and tendon [114] applications. PDLLA is an amorphous polymer 
due to random distribution of L- and D- lactide units and has a glass transition 
temperature of 55-60ºC. Since it is an amorphous material, it shows lower tensile 
strength than PLLA. It loses its mechanical properties after 1-2 months due to 
hydrolysis and mass loss happens within 12-16 months. Since it degrades faster than 
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PLLA and has an amorphous structure which allows a homogeneous distribution of 
the active species it is a better candidate to drug delivery systems. Its degradation 
rate can vary according to the percentage of D- and L- in the polymer structure [94, 
96, 97]. 
4.3.2. Poly(lactide-co-glycolide) (PLGA) 
The result of the copolymerization of PLA (both the L- and the DL-lactides) and PGA 
is PLGA. This is the most investigated copolymer for biomedical applications such as 
sutures, drug delivery systems and scaffolds for tissue engineering. It has great 
availability and processability. Since PLA and PGA have different properties, it is 
possible to adjust the ratios of both polymers and obtain a large range of properties. 
Poly(lactide-co-glycolide) with 25-75% ratio, forms an amorphous polymer, very 
hydrolytically unstable compared to the homopolymers. At 50/50 ratio, the 
copolymer is even more unstable, since the degradation resistance is higher at both 
ends of the copolymer composition range. At this ratio, the copolymer degrades at 
approximately 1-2 months. [94, 115]. The copolymer undergoes bulk erosion through 
hydrolysis of the ester bonds and the degradation rate depends on some parameters 
such as LA/GA ratio, molecular weight and the shape and structure of the matrix. An 
advantage of this polymer is the fact that it is FDA approved for use in humans, and 
its good processability that enables the production of a variety of structures and 
forms and control the degradation rates of the polymer, hence being the most 
investigated copolymer for biomedical applications. PLGA also shows good cell 
adhesion and proliferation, which is essential for tissue engineering applications. 
Many studies have been made using micro- and nano- fabrication techniques to 
create 3D scaffolds based on PLGA [94, 95].  Regarding the enzymatic degradation 
of PLGA, enzymes may enhance the degradation of this polymer but hydrolysis is still 
the main process for the degradation of PLGA [116]. 
PLGA is used widely in biomedical applications including sutures such as Vicryl®, 
Vicryl Rapide®, Panacryl®, PolySorb® and PuraSorb®. It has also been used in drug 
delivery applications [95]. In tissue engineering applications, PLGA has been used to 
produce scaffolds for tendons and ligaments [67, 117], vascular [118], cartilage [119] 
and cardiac [120] applications.  
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4.3.3. Polycaprolactone (PCL) 
Polycaprolactone is a hydrophobic, semicrystalline polymer, obtained primarily by 
ROP of the monomer ε-caprolactone. It has good processability and solubility and 
exceptional blend-compatibility. It has a low melting temperature of 59-64ºC and a 
glass transition temperature of -60ºC. Its crystallinity tends to decrease with the 
increase of molecular weight. PCL undergoes surface hydrolytic degradation by the 
cleavage of the polymer backbone. It is a hydrophobic polymer with a very slow 
degradation rate (can reach up to 3-4 years), therefore it was originally used in drug 
delivery systems that are active for 1 year or more.  It is used on Capronor®, which 
is a commercial contraceptive PCL product that delivers the active substance for 
over a year. It is FDA approved for some medical devices and for drug delivery 
systems [95, 121]. As for the enzymatic degradation of this polymer, it has been 
shown that PCL degrades rapidly in the presence of pseudomonas lipase [104]. When 
compared to other biodegradable polymers, this polymer has superior rheological 
and viscoelastic properties, high permeability to small drug molecules, maintenance 
of a neutral pH environment during degradation, and its slow erosion kinetics 
compared to PLA and PGA, characteristics which are important to biomedical use. 
As a result of these adequate properties for tissue engineering applications, PCL is 
widely used to form copolymers for scaffolds. It has been investigated in many fields 
of tissue engineering such as scaffold for tendons and ligaments [122] 
4.3.4. Polytetrafluoroethylene – (PTFE)  
While not being an aliphatic polyester, PTFE was investigated due to its use in this 
work. Polytetrafluoroethylene is a semi-crystalline fluoropolymer, classified as a 
thermoplastic. It was discovered at the DuPont industry and is mostly known for its 
commercial name Teflon®. This polymer has some characteristic properties such as 
high mechanical strength, high chemical inertness, hydrophobicity and high thermal 
conductivity in composite form. It is a high thermal resistance and high operating 
temperature polymer with a melting temperature between 325ºC and 335ºC. PTFE is 
used in several fields including automotive industries, food processing, 
petrochemical, electrical, chemical and biomedical applications. [123] In the field 
of biomedicine, the application of PTFE includes biliary stents [124], vascular grafts 
[125], tissue engineering [126]. 
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In the 1980s, PTFE, in the form of expanded PTFE began to be used as a ligament 
prosthesis with the name Gore-Tex®, especially in ACL repair. It was approved by 
the FDA for use in patients with previously failed autologous ACL reconstructions. It 
demonstrated very high tensile strength and stiffness. Its goal was to replace the ACL 
permanently and promote fixation and early load-bearing capacity [8]. After good 
preliminary results [127, 128], the ligament prothesis started to show complications 
such as, effusion and pain [129] presence of wear debris [130], and loosening [131]. 
In 1993, it was withdrawn from the market and abandoned in knee instability surgery 
[8]. 
4.5.5. Polydioxanone – (PDS) 
Polydioxanone, known as PDS, PDO, or poly(р-dioxanone), is a colourless, crystalline, 
bioabsorbable polymer mostly known by its clinical use as a monofilament suture. 
This polymer is poly(ester-esther) and was introduced in the market by Ethicon Inc. 
in 1981. It is synthetized by ring-opening polymerization through the monomer 
paradioxanone, or p-dioxanone. This polymer presents a crystalline fraction of 55% 
and Tg is between 0ºC and -10ºC. As a suture, its shows good flexibility, good strength 
retention, slow absorption rates and low inflammatory response [132, 133]. Its shape 
memory characteristic is one important disadvantage for its use as a suture, as it can 
make knot retention difficult. PDS is approved by the FDA to be used as a suture 
material [134]. 
Polydioxanone degrades through hydrolysis in two stages and undergoes a “cleavage-
induced crystallization process”. First the amorphous regions suffer degradation, 
which leads to an increase in crystalline content, followed by the degradation of the 
crystalline regions. [133] When degraded in an enzymatic medium such as bile and 
pancreatic juice mixture, this polymer showed minimal tensile strength changes 
[135]. 
Besides suturing, PDS is also present in applications including orthopaedics [136], 
cardiovascular [137, 138] and bone tissue engineering [139]. Oryan et al. utilized 
polydioxanone as a sheath in a collagen-PDS based tissue engineered graft employed 
to repair a large defect on the Achilles tendon in rabbits. It was concluded that the 
artificial tendon accelerated tendon healing and resulted in a new tendon which was 
biomechanically, biochemically and morphologically tendinous in nature. The 
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tendons regenerated by this artificial tendon also demonstrated better mechanical 
properties than the controls. [140] 
5. Methodology 
In this study, the design of scaffolds and simulation of their mechanical behaviour 
for the regeneration of the Achilles tendon were made based on a simplified 
approach. According to J. Banks [141], a simulation study is composed by a set of 
steps. It begins with a statement of the problem followed by setting the goals of the 
simulation and overall project plan, model conceptualization, data collection. 
With this in mind, the first point was to define the problem. The field of scaffolding 
for ligaments and tendons, while it has been widely studied nowadays, still lacks 
information regarding the ideal composition and the outcomes of the use of synthetic 
biodegradable scaffolds for tendons and ligaments in humans. Especially on the 
mechanical behaviour of the scaffold with degradation time and the properties of 
the resulting tissue. The goal of this work was to design a scaffold and simulate, 
based on a simplified approach, the mechanical behaviour of the scaffold and the 
regenerating Achilles tendon tissue during degradation/regeneration. The function 
of the scaffold is that it should provide mechanical support to the tissue to prevent 
its rupture. This support given by the scaffold is crucial in the earlier stages of 
regeneration, when the regenerating tissue does not yet possess the mechanical 
properties which allow normal load bearing without tissue failure.  
The scaffolds were designed using biocompatible polymers which were previously 
used in biomedical applications. Data regarding the mechanical properties of the 
materials during degradation were obtained from the literature. Regression models 
were employed to obtain the mathematical expressions that represent the evolution 
of those properties with degradation time. The same was made to obtain the 
expressions that translate the growth of the tissue and its mechanical properties. 
Information regarding simulation parameters, scaffold sizing, characteristics of a 
normal Achilles tendon and characteristics of an injured Achilles tendon were also 
obtained from the literature. Two different scaffolds were designed, one fully 
degradable and another semi-degradable, where the fully degradable scaffold was 
composed by biodegradable polymers only and the semi-degradable was composed 
by biodegradable polymers and one non-degradable polymer. The rationale behind 
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the utilization of the semi-degradable scaffold is that, since an Achilles tendon 
presents lower mechanical properties after healing from a total rupture than a 
healthy Achilles tendon, the scaffold would possess a non-degradable portion which 
would provide reinforcement to the weaker tissue even after the healing process is 
concluded. This would result in a scaffold that could degrade partially and promote 
tissue regeneration but also provide permanent mechanical support to the injured 
tendon. The effectiveness of the semi-degradable scaffolds for tissue regeneration 
could be explored further. 
As referred previously, the design of scaffolds is very complex. They must present 
specific characteristics to ensure its success, such as high porosity to promote cell 
attachment and proliferation, not producing debris which would impair the 
environment in situ and exhibiting a stiffness within a certain range. However, in 
this work, the focus was mainly on the mechanical factors. Biological, chemical and 
physiological aspects were disregarded in this model. While seeking to fulfil some of 
the requirements imposed by these aspects in an earlier stage such as using 
biocompatible materials exclusively and designing a scaffold with an initial stiffness 
close to a normal Achilles tendon, other were not considered. For example, PTFE 
which has shown some problems in the field of ligament reconstruction, was used in 
this investigation due to its use in the human body as the FDA approved Gore-Tex® 
artificial ligament.  
The simulation was implemented in a spreadsheet using an algorithmic procedure 
described in Section 5.6. It allowed the input of the expressions that give the 
evolution of the mechanical properties of the elements with time and to study how 
the loads are distributed through the elements at each time step.  
This work was made to approximate in vivo conditions as close as it was possible but 
as this is a simplified model, many aspects do not correspond to the real, in vivo 
conditions. The limitations of this model are discussed further in this work. 
5.1 Data collection  
For the purpose of this investigation, data regarding the evolution of mechanical 
properties during degradation of some polymers, and the evolution of the mechanical 
properties of the Achilles tendon while regenerating from a total rupture were 
collected. All data was collected from the literature for further use in the simulation. 
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In this study, six articles are considered to represent the properties of the 
components (PLA-PCL, PLGA, PDS, PTFE and Achilles tendon tissue). One study to 
represent the mechanical properties of each polymeric material and two to represent 
the Achilles tendon tissue. From the two studies used to represent the natural tissue, 
one study was used to represent the properties of a healthy and a previously ruptured 
Achilles tendon, and another study to represent the evolution of the mechanical 
properties during healing of a total Achilles tendon rupture. 
5.2 Data selection 
The selection criteria were: 
Materials: 
• Materials that could degrade within the human body without promoting any 
prejudicial reactions from the host (Not applied to the non-degradable 
material); 
• Materials with mechanical properties that enable the production of a scaffold 
for the Achilles tendon;  
• Biocompatible materials;  
• Materials that are already approved for use in the human body by the FDA.  
Material data source: 
• Studies that reported the degradation of mechanical properties of the 
selected material; 
• Studies in which the degradation tests were made in vitro and had the goal of 
approximating itself to in vivo conditions (such as degradation medium, 
temperature); 
• Studies on materials that exhibited an evolution of mechanical properties 
suitable for the application, such as Young’s Modulus and tensile strength 
appropriate to the Achilles tendon tissue; 
• Studies that investigated the materials under the form of suture or scaffold 
for comparison purposes. 
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Achilles tendon properties during regeneration data source: 
• Studies that reported the cross-section area and the Young’s Modulus during 
the regeneration of the tissue after rupture; 
• Studies in which the regeneration of the tendon happens after an Achilles 
tendon rupture; 
• Studies in which the Achilles tendon rupture is repaired by surgical suturing 
intervention; 
• Studies performed in humans; 
• Studies where the measurements were made in vivo. 
Injured and the uninjured Achilles tendon data source: 
• Studies in which cross-section area, tensile strength, Young’s Modulus and 
tendon length were measured; 
• Studies in which the injured tendon suffered an Achilles tendon rupture; 
• Studies in which the injured tendon was repaired by surgical intervention for 
coherence purposes. 
In the articles where the same material was presented in different forms e.g. fibres 
with different diameters, the option which would present more appropriate 
characteristics (such as Young’s Modulus and tensile strength) to reach our desired 
scaffold properties was chosen.  
5.3 Data presentation 
As reported before, the materials chosen to compose the scaffolds were PLGA, PLA-
PCL, PDS and PTFE. In table 3, information regarding the studies of the materials 
selected for this investigation is shown. 
In this section, information about each considered research is presented. In ideal 
comparison conditions, all the studies considered should have utilized the same 
material form (fibres), but no suitable data sources investigating the degradation of 
mechanical properties in PLGA in the form of fibres were found. Therefore, a 
research studying PLGA in the form of a knitted fibrous scaffold was considered.  
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Table 3 - Data regarding the studies of the materials chosen for this investigation 
 PLGA PLA-PCL PDS PTFE 
Material 
composition 
10% PLA 
90%PGA 
90%PLA 
10%PCL 
100% PDS 100% PTFE 
Form Scaffold Fiber Fiber Fiber 
Fiber 
diameter 
(mm) 
0.225 0.4 0.15 0.02 
Processing - Melt-spun - Melt-spun 
Molecular 
Weight (Mn) 
- 28000 - 121000 
Degradation 
medium 
Dulbecco’s 
modified 
Eagle 
Medium 
PBS PBS - 
 
• PLGA 
For PLGA, the article chosen was from Vaquette et al. studying the knitted scaffold 
for tissue engineering [52]. 
In their research, Vicryl suture 4-0 (poly (L-lactic-co-glycolic acid) (10/90) was used 
to fabricate a knitted scaffold, 6 stiches wide and 15 rows long with an internal stich 
diameter of 1mm. The average diameter of the fibres was of 225µm. The degradation 
took place in 15 ml tube containing 5ml of Dulbecco’s modified Eagle’s solution at 
37ºC. The degradation medium was changed every 7 days. The samples were tested 
at 0, 7, 21, 28, 35, 42, 49 days of degradation. 
Several characteristics were studied, such as, morphology, mechanical properties, 
degradation, inherent viscosity, pH and weight differences were investigated. For 
the mechanical tests, five samples were tested for each degradation stage. Biological 
evaluation was done, with the fabrication of a composite scaffold with cellularized 
alginate gel encapsulating the PLGA scaffold. For in vivo testing the scaffold was 
coated with alginate gel and fibroblasts in order to promote tissue growth. The data 
utilized in this work is regarding the scaffold without cellularized alginate gel 
encapsulation. 
The tensile tests showed an initial tensile strength of 164MPa, and a Young’s Modulus 
of 765MPa. The degradation of the scaffolds lasted 49 days, but after 42 days the 
scaffolds were too brittle to perform tensile tests. The Young’s Modulus (Eq. 1) and 
the tensile strength (Eq. 2) were modelled using exponential functions.  
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 EPLGA(t) = 251,66e-0,003t (1) 
 σr-PLGA(t) = 1096,6e-0,002t (2) 
 
• Polylactic acid/Polycaprolactone blend – PLA-PCL 
For the PLA-PCL fibres, the data was withdrawn from Vieira’s work [142]. 
The degradation of the mechanical properties of PLA-PCL fibres were studied in PBS 
(phosphate buffer saline), water and NaCl solution for 16 weeks at 37ºC. The fibres 
were inserted in test tubes and submitted to different degradations stages. The 
samples were weighed before and after degradation and GPC (gel permeation 
chromatography), monotonic tensile tests, dynamic mechanical analysis were 
performed, along with biocompatibility, thermal and chemical characterization. For 
this investigation, the data regarding the degradation of PLA-PCL fibres with a 
diameter of 400µm degraded in PBS was used. The composition of the fibres of was 
90%PLA and 10% PCL, with a Tg of 56ºC and Tm (melting temperature) of 157ºC.  
In his study, the author modelled the degradation of the fibres and presents the 
mathematical expression for the loss of tensile strength during the degradation of 
the fibres, shown in Eq. 3, therefore it was not necessary to calculate the model for 
the degradation of tensile strength for this material. 
 𝜎𝑟−𝑃𝐿𝐴−𝑃𝐶𝐿 = 𝜎0𝑒
−𝑘𝑡 (3) 
In this equation, 𝜎0 is the initial tensile strength of the fibre, k a constant which 
depends on the degradation media and t stands for time.  
As for the evolution of the Young’s Modulus of PLA-PCL fibres (Eq. 4), was obtained 
through modelling using the data gathered, using a linear function.  
 EPLA-PCL(t) = 0,7054t + 1197 (4) 
   
• Polydioxanone - PDS 
For PDS, a study from Zilberman et al. regarding the degradation of bioresorbable 
sutures was used [143]. 
In this research, the authors focused on the mechanical properties during in vitro 
degradation of some bioresorbable fibres and stents, using polymers such as PLLA, 
PGACL (poly (glycolic acid-co-ε-caprolactone)) and PDS. For our work, only PDS fibres 
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were considered. PDS was used in the form of monofilament fibres obtained from 
Ethicon, Inc. with a diameter of 0.15mm. 
For the characterization of the fibre samples, fibres were weighed to determine 
weight retention, tensile testing and observation through SEM (scanning electron 
microscopy) were performed. The mechanical properties were studied during in vitro 
degradation over six weeks at 37ºC in PBS solution. Samples were tested every week, 
and five samples were tested for each point.  
In their investigation, PDS showed a moderate tensile strength and Young’s Modulus 
and relatively high ductility when compared to the other tested fibres. The polymer 
presented an initial elastic modulus of 365MPa and a tensile strength of 612MPa. 
After six weeks of degradation, PDS lost 2%wt and preserved its mechanical 
properties partially. The Young’s Modulus (Eq. 5) and the tensile strength (Eq. 6) of 
PDS were modelled using linear functions. 
 EPDS(t)= -0,0418t + 367,3 (5) 
 σr-PDS(t) = -0,2198t + 613,01 (6) 
 
• Polytetrafluoroethylene – PTFE 
To represent the properties of PTFE, a study from Goessi et al. regarding the 
characteristics of different grades of PTFE was chosen [144].  
In their study, they reported a set of PTFE grades in the form of melt-spun 
monofilaments. These fibres were spun at 380ºC and varied in weight-average 
molecular weight, and consequently, in mechanical properties. The fibre diameter 
was of 20µm. The characterisation of the fibres included DSC (differential scanning 
calorimetry), tensile testing and Wide-angle X-ray analysis.  
The fibre grade elected to represent the properties of PTFE used in this study is IX. 
This grade was chosen due to it high Young’s Modulus. This grade exhibits a weight-
average molecular weight of 202kg/mol, a melting temperature of 320ºC. As for the 
mechanical properties, they are shown in table 4. 
Table 4 - Mechanical properties of PTFE 
Property Value 
Tensile Strength (MPa) 176 
Young’s Modulus (MPa) 1656 
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This material was chosen as the non-degradable polymer to be used in the design of 
the semi-degradable scaffold due its previous utilization in biomedical applications 
as Gore-Tex® artificial ligament in knee surgery. As said previously, it is known that 
this artificial ligament led to many problems such as wear debris and loosening, 
however, these aspects are neglected in this simplified model. 
• Natural Achilles Tendon Tissue 
To represent the mechanical properties of the uninjured Achilles tendon and the 
mechanical properties of the injured Achilles tendon after healing, the article chosen 
was from Geremia et al. [145]. 
In their study, an evaluation of early mobilization and traditional immobilization 
after an acute rupture of the Achilles tendon was made, by comparing the stress-
strain and force-elongation relationships of the injured tendon to those of the 
uninjured tendon. A group of males with previous Achilles tendon rupture (n=18) and 
a group of healthy male control participated (n=9). Half of the Achilles tendon 
rupture group have received early immobilization while the other half received 
traditional immobilization with a plaster cast.  
To determine the cross-sectional area, tendon resting length and tendon elongation 
as a function of torque during the maximal voluntary plantar flexion, ultrasound was 
used. Achilles tendon force-elongation and stress-strain relationships were 
determined from these data. In table 5, data regarding an uninjured Achilles tendon 
and a tendon that suffered a total rupture and had a regeneration time of 2 years 
are presented. The values used for the injured tendon are regarding tendons which 
underwent short-term physiotherapy. This choice was based on the studies which 
report that mechanical stimulation enhances tissue regeneration in scaffolds [59-61] 
and studies that report positive results regarding early mobilization after an Achilles 
tendon rupture [28]. 
The value of breaking tensile strength of the Achilles tendon was obtained from [146] 
for a displacement speed of 10mm/s.  
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Table 5 - Properties and characteristics of healthy and injured tendons (*value of tensile strength was obtained from [161]) 
 
• Mechanical Properties of the regenerating Achilles tendon 
To represent the properties of the regenerating Achilles tendon the investigation 
from Schepull et al. was used [147]. 
In this study, the Achilles tendon repair was studied in ten patients with total Achilles 
tendon rupture with RSA (Roentgen stereophotogrammetric analysis). Tantalum 
beads were implanted in surgery. Evaluations were made at 6, 12, 18 weeks and 1 
year. RSA was performed with two different mechanical loadings and the strain 
induced by increasing loading was measured. The transverse area was determined by 
ultrasound.  
The data regarding the evolution of the Young’s Modulus and the cross-section area 
of the Achilles tendon during regeneration are shown in Figure 8 and 9, respectively. 
 
Figure 8 - Values of Young's Modulus during healing from an Achilles tendon rupture obtained from [144] 
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Figure 9 - Values of cross-section area during healing from an Achilles tendon rupture obtained from [144] 
5.4 Modelling the evolution of properties of the materials and the regenerating 
Achilles tendon tissue during degradation/regeneration 
• Materials 
For each material, the evolution of tensile strength and Young’s Modulus throughout 
time was modelled by calculating regression equations with time as predictor of 
property. 
An example of this procedure is shown in Figure 10. The values of Young’s Modulus 
of PDS during degradation (shown in table 6) were retrieved from [143]. This was 
followed by the calculation of the regression model. The selection of the type of 
function was determined by comparing the percentage of variance explained or 
coefficient of determination (R2) for linear vs higher order models and based on 
published results.  
Table 6 - Values of Young's Modulus of PDS fibres during degradation gathered from [140] 
Time (Hours) Young’s Modulus (MPa) 
0 365 
168 359 
336 358 
504 346 
672 339 
840 333 
1008 323 
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Figure 10 - Illustrative example for the modelling of Young's Modulus throughout time. In this case a linear model explains 
97% of the variance of degradation. 
The equations obtained thus describe the evolution of each property with time. This 
process was repeated to model the evolution of Young’s Modulus and tensile strength 
of all the materials used. The evolution of the properties of the all the materials 
were modelled using linear or exponential functions. The regression models for the 
mechanical properties of the materials are shown in Annex A. 
• Regenerating tissue  
To obtain the functions regarding the regeneration of the tissue and its properties, 
the same method was used, with one additional feature. Limits were applied to the 
functions to avoid continuous growth. The limits applied are based on published 
results regarding the properties of the Achilles tendon after two years of healing 
from a total rupture [145]. In this work, these values are assumed to represent full 
regeneration. The evolution of Young Modulus with time, during the regeneration of 
tendon tissue, was modelled following the same reasoning. 369MPa was considered 
the upper value (withdrawn from [145]), therefore the initial Young’s Modulus is of 
0MPa and increases until 369MPa. The regression model used, and the evolution of 
the Young’s Modulus can be seen in Figures 11 and 12, respectively. 
For the cross-section area the same process was applied. In this case, studies indicate 
that the evolution throughout time is not linear, but rather best described as a 
quadratic function (increase followed by decrease) [148, 149]. For this reason, a 
polynomial trendline was used. As before, a limit was also applied (obtained from 
[145]) to avoid continuous evolution.  
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Figure 11 - Linear regression model using the data gathered of the Young's Modulus for the Achilles tendon during 
regeneration 
 
Figure 12 - Evolution of the Young's Modulus of the Achilles tendon during regeneration using the regression model and 
considering the assumed limit 
The simulated evolution of the cross-section area is in agreement to what was found 
in the literature [148, 149] as it increases greatly and then, decreases after a few 
months until it stabilizes to a value higher than of a normal Achilles tendon. One 
important issue here is that the values of cross-section area gathered for this work 
were obtained from a study where a ruptured tendon is repaired via surgery where 
the two ends are sutured, and a localized callus is formed. If the measurements of 
the cross-section area were performed in the zone where the callus is formed, the 
cross-section area obtained may not represent the cross-section of the whole tendon. 
In our case, the equation that was obtained from the regression model, generated 
unrealistic results. Due to this, the mathematical expression was multiplied by a 
factor of 0.5, which resulted in an evolution of the parameters closer to what was 
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found in the literature [145]. The regression model used, and the evolution of the 
cross-section area is shown are shown in Figures 13 and 14 respectively. 
 
Figure 13 - Regression model obtained using the data gathered of the cross-section area for the Achilles tendon during 
healing from a rupture 
 
Figure 14 - Evolution of the cross-section area during regeneration using the regression model and considering the assumed 
limit 
As for the evolution of the breaking tensile strength during regeneration of the 
Achilles tendon after rupture and the value of breaking tensile strength of a fully 
healed Achilles tendon after rupture, no data was found. Due to this, making 
assumptions regarding the evolution of the tensile strength and the value of breaking 
tensile strength of the fully healed Achilles tendon tissue was necessary. It was 
assumed that the tensile strength of the tissue had the same behaviour as the Young’s 
Modulus, being directly proportional. Therefore, as the Young’s Modulus of the 
Achilles tendon after two years of regeneration is close to half of the value for the 
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uninjured Achilles tendon, the same situation was assumed to happen for the tensile 
strength. 
Therefore, if the tensile strength of a healthy Achilles tendon is 86MPa, as shown in 
table 5, it was assumed that for the regenerating tendon, the tensile strength 
increases up to 43MPa (which is half of the tensile strength of a healthy Achilles 
tendon found in [146]) and then ceases to evolve. Since the time needed for the 
Young’s Modulus to reach its maximum value was close to one year, the same interval 
of time was set for the tensile strength of the regenerating tissue to reach its peak. 
The model for the evolution of the breaking tensile strength of the regenerating 
tendon was calculated using two points only, the initial value (σr=0MPa) and the 
tensile strength after one year of regeneration (σr=43MPa), which is maximum value. 
The model obtained using this process is shown in Figure 15. 
 
Figure 15 - Method used to obtain the model for the tensile strength of the Achilles tendon during regeneration 
This equation was used to simulate the evolution of the tensile strength of the 
regenerating tissue. After reaching 43MPa, it does not develop further. Equations 7, 
8 and 9 were obtained and translate the evolution of the tensile strength, Young’s 
Modulus and cross-section area of the tissue, respectively.  
 σr-tissue = 0.0057t (7) 
 Etissue = 0.049t (8) 
 Atissue = (-1.4E-05t2 + 0,1508t) x 0.5 (9) 
The evolution of the tensile strength of the regenerating tissue is shown in Figure 
14. 
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Figure 16 – Evolution of the tensile strength obtained using the regression model and the assumed limit 
Due to the model used to define the evolution of the tensile strength being 
calculated based on assumptions only, it was necessary to investigate if there is some 
information that could corroborate the assumption made. 
A study concerning the regeneration of the Achilles tendon in rabbits was found [46]. 
To validate the model used for the evolution of the tensile strength in this work, 
another model was built, for comparison purposes, using the information obtained 
from the study regarding the evolution of the tensile strength of the Achilles tendon 
during healing. This model exhibited a high coefficient of determination (R2=0.91), 
thus corroborating, to a certain level, the type of function (linear) used to model the 
evolution of tensile strength in this work. The model is shown in Figure 17. 
 
Figure 17 - Model obtained for comparison regarding the evolution of tensile strength from [43] 
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Figure 18 - Illustration of the scaffold's architecture 
In another attempt to validate the assumptions made, this time to verify the value 
which was assumed to be the limit of the evolution of the tensile strength of tendon 
after healing (43MPa), a study in a sheep model, also regarding the regeneration of 
the Achilles tendon was considered [148]. It was observed that after one year of 
healing of a total rupture, the Achilles tendon exhibited a tensile strength of 56.7% 
of the value for the healthy tendon. This legitimizes, to some extent, the assumption 
made, since our hypothesis suggests that the tensile strength of the Achilles tendon 
regenerates until 50% of the healthy tendon value. Due to lack of information, the 
assumptions referred previously were necessary to enable the development of a 
model regarding the evolution of the tensile strength to allow the construction of 
the simulation. A large difference is not detected when comparing the results.  
While these comparisons cannot ensure that the model used for the evolution of the 
tensile strength is close to the real evolution, they suggest that the probability of 
the model being completely unrealistic is quite low.  
5.5. Scaffold Design 
 
The design of the scaffolds consisted in determining its composition and its structure. 
The structure of this simplified model is formed by parallel fibres aligned in the 
direction of loading, as shown in Figure 20. This simple architecture is stripped from 
structural complexity, which simplifies the equations equilibrium deduced to 
correlate forces and displacements.  
 
 
 
 
 
 
 
 
The composition of the scaffold is achieved through calculations to obtain the desired 
mechanical behaviour. The procedures were based on the Young’s Modulus of the 
fibres and the initial stiffness which was defined for the scaffold. Some 
Scaffold 
237mm 
8,74mm 
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characteristics of the scaffold were defined in advance i.e. the scaffold’s Young’s 
Modulus, length, cross-section area and the diameter of the fibres. These values 
were stipulated to be close to the characteristics of a healthy Achilles tendon 
represented in table 7. The diameter of the fibres was chosen to be similar to the 
collagen fibres diameter found in [150]. It was assumed that all the fibres had the 
same diameter with purpose of simplification. The initial Young’s Modulus of the 
scaffold was defined to be 1000MPa, which is roughly 18% higher than a healthy 
Achilles tendon (according to [145]), in order to provide support to the regenerating 
tissue in the earlier stages. 
Table 7 - Characteristics of the scaffolds 
Scaffold Characteristics Value 
Length (mm) 237 
Cross-section area (mm2) 60 
Young’s Modulus (MPa) ≈1000 
Fibre Diameter (mm) 0.03 
 
As stated in [5], the stiffness of the scaffold should be designed according to the 
natural tissue in its linear region. In such approach, the scaffold had the form of a 
braided cord that, depending on the twist, could replicate the stiffness in the toe 
region. In this work, the toe region will not be considered, as it will be assumed that 
the natural tissue has a linear elastic behaviour. Despite the difference of the 
architectures, the same process can be applied to calculate the modulus of the 
structure. The modulus of the scaffold can be calculated through the law of mixtures. 
The stresses in the fibrous structure can be calculated if some assumptions are made: 
• All fibres extend the for same amount i.e. the length of the scaffold; 
• All fibres are aligned in the direction of loading; 
• The materials have a linearly elastic behaviour; 
• There are no void spaces between fibres; 
• The load is equally shared by the fibres i.e. proportional to stiffness; 
The load sustained by the fibrous structure is given by: 
 
𝑃𝑠𝑐𝑎𝑓𝑓𝑜𝑙𝑑 = ∑ 𝑃𝑖
𝑛
𝑖=1
 (10) 
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with 𝑃𝑠𝑐𝑎𝑓𝑓𝑜𝑙𝑑 representing the load supported by the scaffold and 𝑃𝑖 representing the 
load supported by the fibres of the materials. 
Since in tensile load 𝑃𝑠𝑐𝑎𝑓𝑓𝑜𝑙𝑑 =  𝜎𝑠𝑐𝑎𝑓𝑓𝑜𝑙𝑑 × 𝐴𝑠𝑐𝑎𝑓𝑓𝑜𝑙𝑑, and medium stress 𝜎𝑠𝑐𝑎𝑓𝑓𝑜𝑙𝑑 ×
𝐴𝑠𝑐𝑎𝑓𝑓𝑜𝑙𝑑 = ∑ 𝜎𝑖 × 𝐴𝑖
𝑛
𝑖=1  where 𝜎𝑖  is the stress supported and 𝐴𝑖  the cross-section area 
of the fibres of a material.  
Assuming the isostrain condition, it is obtained that: 
 𝜀𝑠𝑐𝑎𝑓𝑓𝑜𝑙𝑑 = ε1 = ε2 = ⋯ = ε𝑖  (11) 
With 𝜀𝑠𝑐𝑎𝑓𝑓𝑜𝑙𝑑 representing the strain of the scaffold and ε1, ε2, ε𝑖 representing the 
strain of the fibres of the materials. 
Through the division of eq. 2 and 3, and since Young’s Modulus 𝐸 =  
𝜎
𝜀
 : 
 
𝐸𝑠𝑐𝑎𝑓𝑓𝑜𝑙𝑑𝐴𝑠𝑐𝑎𝑓𝑓𝑜𝑙𝑑 = ∑ 𝐸𝑖𝐴𝑖
𝑛
𝑖=1
 (12) 
With 𝐸𝑠𝑐𝑎𝑓𝑓𝑜𝑙𝑑 representing the Young’s Modulus and 𝐴𝑠𝑐𝑎𝑓𝑓𝑜𝑙𝑑 representing the cross-
section area of the scaffold and 𝐸𝑖 representing the Young’s Modulus and 𝐴𝑖 
representing the cross-section area occupied by the fibres of the materials. 
As the fibres have the same length and cross-section area, then the cross-section 
area of each fiber will equal its respective volume fraction (𝑉𝑖):  
 
𝐸𝑠𝑐𝑎𝑓𝑓𝑜𝑙𝑑 = ∑ 𝐸𝑖𝑉𝑖
𝑛
𝑖=1
 (13) 
Knowing the initial Young’s Modulus of each material that composes the scaffold, 
this method allowed the calculation of the appropriate volume fraction of each 
material so that the scaffold could possess the desired Young’s Modulus.  
Since the voids between fibres are not being accounted for, therefore the number of 
fibres that form the scaffold (𝑁𝑓𝑠𝑐𝑎𝑓𝑓𝑜𝑙𝑑) may be given by the division between the 
cross-section area of the fibre (𝐴𝑓𝑖𝑏𝑟𝑒) and the initial cross-section area of the 
scaffold (𝐴𝑠𝑐𝑎𝑓𝑓𝑜𝑙𝑑).  
 𝑁𝑓𝑠𝑐𝑎𝑓𝑓𝑜𝑙𝑑 = 𝐴𝑓𝑖𝑏𝑟𝑒/𝐴𝑠𝑐𝑎𝑓𝑓𝑜𝑙𝑑 (14) 
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The number of fibres of each material (𝑁𝑓𝑖) can be obtained by multiplying the 
volume fraction of the material in the scaffold for the total number of fibres in the 
scaffold. 
 𝑁𝑓𝑖 = 𝑉𝑖 × 𝑁𝑓𝑠𝑐𝑎𝑓𝑓𝑜𝑙𝑑 (15) 
Whenever the number of fibres is not an integer, the value was rounded up to the 
next integer. 
Through these calculations the volume fractions of each material were achieved. 
The characteristics of the scaffolds are shown in tables 8 and 9. 
• Degradable scaffold properties 
Table 8 - Characteristics of the degradable scaffold 
Properties Value 
Initial Young’s Modulus (MPa) 1077 
Total number of fibres 84883 
Number of fibres - PLGA 21221 (Vol. fraction PLGA=0.25) 
Number of fibres - PDS 35650 (Vol. fraction PDS=0.42) 
Number of fibres - PLA-PCL 28012 (Vol. fraction PLA-PCL=0.33) 
 
• Semi-Degradable scaffold Properties 
Table 9 - Characteristics of the semi-degradable scaffold 
Properties Value 
Initial Young’s Modulus (MPa) 1000 
Total number of fibres 84883 
Number of fibres - PLGA 11884 (Vol. fraction PLGA=0.14) 
Number of fibres - PDS 38197 (Vol. fraction PDS=0.45) 
Number of fibres - PTFE 34802 (Vol. fraction PLA-PCL=0.41) 
 
The polymers selected to compose the scaffolds were chosen based on their 
mechanical properties and their degradation rates. The scaffolds are constituted by 
fibres of three different materials, with different Young’s Modulus and degradation 
rates. Each scaffold is composed by fibres with relatively low stiffness (PDS), medium 
(PLGA) and high stiffness (PLA-PCL for the degradable and PTFE for the semi-
degradable scaffold). This provides a versatile mechanical behaviour to the scaffold, 
as it is composed by materials with different mechanical properties. The different 
degradation rates presented by the polymers indicate that they will rupture in 
different stages. This is a crucial aspect in the design of the scaffold, in order for 
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the load transference from the scaffold to the tissue to be gradual.  The volume 
fractions of the polymers were calculated as a function of the Young’s Modulus of 
the fibres in order for the load to be distributed throughout the fibres. If the stiffest 
material of the scaffold presents a very high volume fraction, this means that, at the 
time when the fibres of that material rupture, the high amount of load supported by 
these fibres would instantly be transferred to the tissue (and other fibres if they did 
not rupture at that time), thus leading to an abrupt load transference. The volume 
fraction of the non-degradable portion of the semi-degradable scaffold (PTFE) was 
calculated to fix the Young’s Modulus of the set at values closer to a healthy Achilles 
tendon (≈600MPa) after the degradation of the degradable polymers. 
5.6 Simulation 
In the simulation, the expressions which deliver the evolution of the mechanical 
properties of the regenerating tissue and the materials as a function of time were 
applied. Through the evolution of the properties of the materials, the behaviour of 
the scaffold could be modelled and plotted with the growth of the regenerating 
tissue. More specifically, by the relationship between these properties and other 
parameters, such as load supported and strain, these quantities could be calculated 
for the elements in the simulation. These quantities will be referred further with 
their respective calculation method. This allowed the observation of how the 
scaffold would perform and if it is fulfilling its goal of supporting the tissue 
mechanically or if the regenerating tissue is being excessively loaded due to poor 
reinforcement and fails. 
The degradable and semi-degradable scaffolds were simulated in the isostrain and 
the isostress condition. This results in different methods of calculation of the 
parameters and different parameters to be calculated. For example, in the isostrain 
condition, the load generated by strain of the elements is calculated. While in the 
isostress condition, the strain provoked by the load in the elements is calculated. 
Therefore, in the calculation methods, there are parameters which are only 
calculated to one of the conditions. The values of constant force and strain are shown 
in table 10.  
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Table 10 - Conditions applied to the scaffolds in the simulation 
Condition Value 
Isostrain – Constant strain 0.03 
Isostress – Constant force (N) 2200 
 
These values were based on the force and elongation experienced by the Achilles 
tendon during walking at a speed of 0.75m/s. The method used to obtain these values 
was Direct Tendon estimation [21].  
After setting the initial conditions, the calculations proceed to determine the forces 
acting on the fibres, on the tissue and on the scaffold during the regeneration of the 
tendon, for each time step. For calculation purposes, in the simulation, four 
elements were distinguished: the materials, the regenerating tissue, the scaffold and 
the whole set. The materials represent the polymer fibres used to build the scaffold. 
In this instance, the calculations were grouped individually for each polymer type. 
The regenerating tissue is the regenerating Achilles tendon tissue whose mechanical 
properties are expected to increase. The scaffold consists on the whole structure 
which is formed the materials, thus the calculations are made by grouping the fibres 
by material type. Afterwards, the set is the union between the scaffold and the 
regenerating tissue, which supports all the external load.  
It is important to differentiate inputs and outputs. Inputs include information that is 
inserted such as the cross-section area occupied by the fibres of each material, the 
mechanical properties evolution functions, volume fraction of each material, 
constant strain and constant stress. Outputs are information that is obtained from 
the simulation, such as load and strain supported by the elements. The outputs 
obtained through the simulation are presented below along with their respective 
calculation method. These parameters were calculated for each time step.  
➢ Materials 
For the materials (PLA-PCL, PLGA, PDS, and PTFE), the Maximum load, Total load, 
effective load, cross-section area and Young’s Modulus × Cross-section area were 
calculated. 
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• Failure load - Pmaxi 
Failure load of the material 𝑖 (Pmaxi) at a given time step was obtained by multiplying 
the tensile strength at the same time step by the initial cross-section area of the 
material 𝑖 (A0i). The initial cross-section area occupied by the fibres of the material 
𝑖 is given by the multiplication of the initial cross-section of the scaffold (A0scaffold) 
by the volume fraction of the material (Vi). 
 𝐴0𝑖 = 𝑉𝑖 × 𝐴0𝑠𝑐𝑎𝑓𝑓𝑜𝑙𝑑 (16) 
 𝑃𝑚𝑎𝑥𝑖 = 𝜎𝑖 (𝑡) × 𝐴0𝑖 (17) 
 
• Total load – Pi 
The total load of the supported by the fibres of a material was calculated by 
multiplying the initial cross-section area of the material 𝑖, imposed strain and the 
Young’s modulus of the material at that time step: 
 𝑃𝑖 = 𝐸(𝑡) × 𝐴0𝑖 × 𝜀  (18) 
• Effective load – Pefi 
The effective load is a condition used to define if the fibres were intact or if they 
ruptured due to excessive loading. If the load supported by the fibres of a material 
is lower than their failure load (Pi < Pmaxi), then Pefi = Pi. On the other hand, if the 
load supported by the fibres is greater than their failure load (Pi > Pmaxi), then Pefi 
= 0 which means the fibres of the material 𝑖 ruptured. 
• Cross-section area – Ai 
This condition was used to define the cross-section area as function of time, because 
when the fibres of a material break, the cross-section area occupied by the fibres 
cannot be accounted for. Therefore, if the fibres of the material 𝑖 have failed 
(Pefi=0), this condition takes the value of zero. If (Pefi > 0), it takes the value of the 
initial cross-section area occupied by the fibres of the material 𝑖.  
• Young’s Modulus × Cross-section area – EAi 
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This parameter was used to further determine the load supported by the scaffold. It 
was calculated by the multiplication of two functions of time, the Young’s Modulus 
and the cross-section area.  
 𝐸𝐴𝑖 = 𝐸𝑖(𝑡) × 𝐴𝑖(𝑡) (19) 
➢ Regenerating tissue 
For the regenerating tissue, parameters such as Maximum load, Total load, 
Effective load and Young’s Modulus x Cross-section area were determined for each 
time step. The Young’s Modulus, Tensile strength and cross-section area of the 
regenerating tissue were obtained previously in section 5.4. 
• Failure load - Pmaxtissue 
Failure load of the regenerating tissue was calculated by the division of the tensile 
strength of the tissue and its cross-section area as shown in eq. 13: 
 𝑃𝑚𝑎𝑥𝑡𝑖𝑠𝑠𝑢𝑒 = 𝜎𝑟−𝑡𝑖𝑠𝑠𝑢𝑒(𝑡) ×  𝐴𝑡𝑖𝑠𝑠𝑢𝑒(𝑡) (20) 
• Total load - Ptissue 
Total load supported by the regenerating tissue was obtained by multiplying the 
Young’s Modulus and cross-section area of the tissue and the imposed strain as in 
eq. 14: 
 𝑃 𝑡𝑖𝑠𝑠𝑢𝑒 = 𝐸𝑡𝑖𝑠𝑠𝑢𝑒(𝑡) × 𝐴𝑡𝑖𝑠𝑠𝑢𝑒(𝑡) × 𝜀 (21) 
   
• Effective load - Peftissue 
The effective load of the tissue is a condition identical as the one used for the 
materials. If Pmaxtissue > Ptissue, then Peftissue = Ptissue. If Pmaxtissue < Ptissue, then Peftissue=0 
• Young’s Modulus x Cross-section area - EAtissue 
Young’s Modulus x Cross-section area of the regenerating tissue by multiplying the 
Young’s Modulus of the tissue by its cross-section area. 
 𝐸𝐴𝑡𝑖𝑠𝑠𝑢𝑒 =  𝐸𝑡𝑖𝑠𝑠𝑢𝑒(𝑡) × 𝐴𝑡𝑖𝑠𝑠𝑢𝑒(𝑡) (22) 
➢ Scaffold 
For the scaffold, the evolution of total load, Young’s modulus, total stress and 
cross-section area were calculated. As said previously, the total load supported by 
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the scaffold equals the sum of the load supported by each fiber. The properties of 
the scaffold are calculated combining the parameters of the fibres. The strain (in 
the isostress condition) is not calculated for the scaffold, as it is not the scaffold 
that regulates the strain, it is the sum of the scaffold and the regenerating tissue 
(set). 
• Total load - Pscaffold  
The total load of the scaffold was calculated by sum of the loads supported by the 
fibres. 
 
𝑃𝑠𝑐𝑎𝑓𝑓𝑜𝑙𝑑 = ∑ 𝑃𝑒𝑓𝑖
𝑛
𝑖=1
 (23) 
• Cross-section area - Ascaffold 
The cross-section area of the scaffold was calculated by the sum of the cross-section 
areas of the materials, as shown in Eq. 16. 
 
𝐴𝑠𝑐𝑎𝑓𝑓𝑜𝑙𝑑 = ∑ 𝐴𝑖
𝑛
𝑖=1
 (24) 
 
• Young’s Modulus - Escaffold 
The Young’s Modulus of a scaffold was calculated by the sum of the Young’s Modulus 
of each material multiplied by the fraction between the cross-section area of the 
material and the cross-section area of the scaffold at that time step: 
 
𝐸𝑠𝑐𝑎𝑓𝑓𝑜𝑙𝑑 = ∑ 𝐸𝑖 ×
𝐴𝑖
𝐴𝑠𝑐𝑎𝑓𝑓𝑜𝑙𝑑
𝑛
𝑖=1
 (25) 
 
➢ Set (Scaffold plus regenerating tissue) 
The parameters of the whole set (scaffold plus regenerating tissue) were calculated. 
Parameters such as total load, Young modulus, cross-section area, strain were 
calculated.  
• Cross-section area - Aset 
The cross-section area of the set is equal to the sum of the cross-section area of the 
scaffold and the cross-section area of the regenerating tissue. 
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 𝐴𝑠𝑒𝑡 = 𝐴𝑠𝑐𝑎𝑓𝑓𝑜𝑙𝑑 + 𝐴𝑡𝑖𝑠𝑠𝑢𝑒(𝑡) (26) 
 
• Young’s Modulus - Eset 
The Young’s Modulus is obtained by multiplying the sum of the multiplication 
between the Young’s Modulus of the scaffold and the fraction between the cross-
section area of the scaffold and the cross-section area of the set and the 
multiplication between the Young’s Modulus of the fraction between the cross-
section area of the regenerating tissue and the cross-section area of the set. 
 
𝐸𝑠𝑒𝑡 = 𝐸𝑠𝑐𝑎𝑓𝑓𝑜𝑙𝑑 ×
𝐴𝑠𝑐𝑎𝑓𝑓𝑜𝑙𝑑
𝐴𝑠𝑒𝑡
+ 𝐸𝑟𝑒𝑔.𝑡𝑖𝑠𝑠𝑢𝑒 ×
𝐴𝑡𝑖𝑠𝑠𝑢𝑒(𝑡)
𝐴𝑠𝑒𝑡
 (27) 
 
• Total load - Pset (Isostrain condition) 
The total load of the set was obtained by multiplying the strain and the sum of the 
Young’s Modulus × Cross-section area of each material and the regenerating tissue. 
 
𝑃𝑠𝑒𝑡 = 𝜀0 ×  (𝐸𝐴𝑡𝑖𝑠𝑠𝑢𝑒 + ∑ 𝐸𝐴𝑖
𝑛
𝑖=1
) (28) 
• Strain - ε (Isostress condition) 
The strain of the set is calculated by the division of the load supported by the scaffold 
and the tissue and sum of Young’s Modulus × Cross-section area of the materials and 
the regenerating tissue: 
 
𝜀 =
𝑃0
𝐸𝐴𝑡𝑖𝑠𝑠𝑢𝑒 + ∑ 𝐸𝐴𝑖
 (29) 
• Stiffness - Sset 
The stiffness of the set is calculated by the load supported by the set and the 
displacement produced, as shown in Eq. 30 
 
𝑆𝑠𝑒𝑡 =
𝑃𝑠𝑒𝑡
𝐿 × 𝜀
 (30) 
The calculation scheme was different for both conditions. For the isostrain condition, 
the procedure was simple. First, every parameter regarding the materials was 
calculated as well as the parameters for the regenerating tissue. The calculations of 
the materials led to the calculations of the scaffold which, then led to the 
calculations of the set.   
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For the isostress condition, the same did not happen. In the isostrain condition, the 
strain is given as a constant condition, which makes it possible to calculate the total 
load and consequently the “Effective load” (parameter which indicates the breakage 
of the materials) of the materials before calculating the parameters for the other 
elements.  
In the isostress condition, the force is given as a constant, thus the calculation of 
the strain of the set is necessary to then determine the total load and effective load 
supported by the fibres. Therefore, the evolution of the Young’s Modulus x Cross-
section area of the fibres of each material and the regenerating tissue were 
calculated to determine the evolution of the Young’s Modulus of the set and its 
strain. Only then, the total load and effective load of each fibre were calculated. 
The fact that the strain of the set is calculated through the Young’s Modulus and 
cross-section area of the materials to, then, calculate the load supported by each 
fibre indicates that the loads supported by the fibres are interdependent. This 
relationship between the fibres allows the study of the transference of load between 
fibres and tissue. 
This brings one problem to the simulation. The value of effective load supported by 
each material is calculated using the strain of the set. However, the value of the 
strain also should depend on the effective load of the materials i.e., the effective 
load determines when fibres of a material rupture, and when this happens, it has an 
impact on the strain due to lesser material supporting the load. Obviously, when 
these interdependences are introduced in the spreadsheet, it generates an error due 
to circular referencing (cell trying to calculate itself). So, if the effective load is 
simply the condition that returns zero when the load supported by the fibres is 
greater than its failure load, for the simulation to work with without errors, it was 
necessary to determine the point when the load supported by the fibres of a material 
exceeds its failure and change the Young’s modulus of the material in question to 
zero, manually. This was done for all materials. As for the regenerating tissue, it 
followed the same procedure to inspect if it had ruptured. Diagrams illustrating the 
steps followed to perform the simulation in the Isostress and in the Isostrain condition 
are presented in Annex B. 
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6. Results and discussion 
6.1 Degradable Scaffold  
• Isostress 
In the isostress condition simulation, the scaffolds are subjected to a constant load 
of 2200N. This condition allows the study of a fundamental aspect: the load 
transference from the degrading scaffold to the regenerating tissue. The load should 
be gradually transferred to the tissue, as it regenerates, and at the point that the 
scaffold loses its properties and all the load is transferred to the tissue, the 
properties of the tissue should have already developed enough for the tissue to 
withstand the load fully. Because the amount of load supported each fibre is 
dependant of its stiffness, the Young’s Modulus of the scaffold must be well adjusted.  
As can be seen is figure 19, the Young’s Modulus of the scaffold is initially close to 
1000MPa, as established in Section 5.5, and shows an increase with time. This is due 
to the rupture of the fibres, first of PLGA and then of PDS. As these polymers have a 
lower Young’s Modulus than the PLA-PCL fibres, when they rupture, the Young’s 
Modulus of the structure increases as the scaffold is composed by stiffer fibres only. 
In figure 20, the Young’s Modulus of the set is shown, it exhibits a major decrease in 
the first 1400 hours (58 days) due to the degradation of the mechanical properties 
of the polymers. It then stabilizes due to the balance between the degradation of 
the polymers and the increase of the tissue’s mechanical properties. 
 
Figure 19 - Evolution of the Young's Modulus of the degradable scaffold and the regenerating tissue 
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Figure 20- Evolution of Young's Modulus of the set using the degradable scaffold during regeneration 
The parameter exhibited in Figure 21 is the “Effective load” of the tissue. This 
parameter, as explained in Section 5.6, controls the breakage of elements by 
reducing the load to zero if, at some point, the load supported by the element 
surpasses the maximum load that the element can undergo. Therefore, by analysing 
the evolution of the load on the tissue, it can be concluded that the scaffold 
adequately provided mechanical support to the tissue, as it prevented the tissue 
from rupturing at any point, especially in the early stages of regeneration.  
 
Figure 21- Evolution of the load supported by the regenerating tissue during the degradation of the degradable scaffold 
In Figure 22, the transference of load from the scaffold to the tissue is shown.  It is 
possible to observe that the load is gradually transferred to the tissue until the 
rupture of the scaffold. At that point, the tissue is already able to withstand the load 
fully. 
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Figure 22 - Evolution of the load supported by the degradable scaffold and the regenerating tissue 
As expected, a symmetry is obtained because, obviously, when the load decreases 
on one element, it increases the same amount on the other.  
In Figure 23, the evolution of the strain of the set is represented. The strain is a 
function of the Young’s Modulus and the cross-section area and its evolution can be 
explained by the evolution of these parameters.  
 
Figure 23 - Evolution of the strain of the set using the degradable scaffold 
Until approximately 750 hours, an increase in strain can be seen, which is caused by 
the decrease of the Young’s Modulus of the polymers due to degradation. This results 
in the decrease of the Young’s Modulus of the set. The following decrease in strain, 
from 1500 to 3300h (except for a minor raise at 2900h due to the rupture of PDS 
fibres), is explained by the increase of the Young’s Modulus and cross-section area 
of the regenerating tissue. At this point, the scaffold is losing its properties and the 
tissue is increasing its properties. Therefore, the evolution of the strain of the set is 
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regulated by the balance between the loss of properties of the scaffold and the 
increase of properties of the tissue. Not only the Young’s Modulus of the tissue is 
increasing, the cross-section area is also increasing, which affects the strain of the 
set directly.  
The rupture of the fibres at 3372h results in the peak strain of 8%. Afterwards, the 
strain still exhibits some variation which is connected to the fact that the Young’s 
Modulus of the tissue is still increasing, and the cross-section area is decreasing. 
After 7500h, the Young’s Modulus of the tissue already stabilized thus the evolution 
of the strain is controlled entirely by the decrease of the cross-section area of the 
tissue. 
In Figure 24, the stiffness of the set is shown. The rupture of the fibres of each 
material are easily identifiable. The values of stiffness do not vary greatly except for 
the rupture of PLA-PCL, when a significant drop in occurs, at 3372 hours. These 
substantial variations are not desired and should be avoided if possible. The tissue 
recovers afterwards and stabilizes at values close of a healthy tendon (see table 5). 
Analysing the stiffness and the Young’s Modulus of the fully regenerated tissue, it 
can be observed that the Young’s Modulus decreases to less than half of a healthy 
tendon, but its stiffness does not experience the same variation. This suggests that 
the decrease in the modulus of the tissue is balanced by the increase in cross-section 
area of the regenerating tendon.  
 
Figure 24 - Evolution of the stiffness of the set using the degradable scaffold 
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• Isostrain 
In the isostrain condition all elements are strained equally, which means that the 
load supported by each fibre is independent of the load supported by the other fibres 
or tissue. The load supported by the fibres and tissue depends solely on their Young’s 
Modulus, cross-section area and their evolution with degradation time. This is clear 
through analysis of the equation used to calculate loads in the isostrain condition, 
since the load is given by the multiplication of the strain (constant) and the Young’s 
Modulus and the cross-section area. The simulation in isostrain condition allows the 
study of the loads generated by the scaffold and the tendon under a strain level 
associated with normal locomotion in the Achilles tendon.  
For the isostrain condition, the results for the evolution of the Young’s Modulus and 
stiffness of the scaffold and the set were almost identical with only difference being 
that the scaffold ruptured 10 days earlier. Since the load experienced by the fibres 
is independent of the load sustained by the other fibres, the presence of the scaffold 
does not affect the load supported by the regenerating tissue. However, studying the 
force generated in the scaffold and in the regenerating tissue as a function of their 
Young’s Modulus is of interest, as well as if they fail under this level of strain. 
In Figure 25, the force generated in the regenerating tissue and the scaffold is shown. 
 
Figure 25 – Evolution of the load supported by the regenerating tissue and the degradable scaffold in the isostrain condition 
The load on the tissue increases with time, as a function of its modulus, reaching 
1850N and then decreases again due to the decrease in cross-section area. The tissue 
endured the strain without breaking, which means that it can be exposed to strains 
associated with walking without rupturing.  
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In Figure 26, the load supported by the set can be seen. The rupture of the PDS and 
PLA-PCL fibres are clear, as well as the effect of the evolution of the Young’s Modulus 
and the cross-section area of the regenerating tissue. The Young’s Modulus increases 
until approximately 7000h. This leads to an increase in the load generated in the 
tissue in that period of time followed by a decrease which is the result of the 
reduction of the cross-section area of the tissue, since it is the only parameter which, 
at that time point, is still evolving. 
 
Figure 26 - Evolution of the load supported by the set using the degradable scaffold in the isostrain condition 
6.2 Semi-Degradable scaffold 
• Isostress 
As can be seen in Figure 27, the semi-degradable scaffold, exhibits two sudden 
increases, in its Young’s Modulus, at 1600h and 2700h, due to the rupture of PLGA 
and PDS fibres respectively. The Young’s Modulus of the scaffold stabilizes at 
1656MPa, where the scaffold is composed only by the non-degradable portion, PTFE. 
In this case, as the scaffold is not completely degradable, the regenerating tissue 
never supports the load fully, as the PTFE does not degrade and keep its mechanical 
properties constant. 
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Figure 27 - Evolution of the Young's Modulus of the semi-degradable scaffold and the regenerating tissue in the isostress 
condition 
In Figure 28, the Young’s Modulus of the set is shown. 
 
Figure 28  - Evolution of Young's Modulus of the set using the semi-degradable scaffold in the isostress condition 
Even though that the scaffold has an increase in its modulus, the set decreases its 
modulus due to the low modulus of the regenerating tissue at that point. Later, the 
modulus begins to increase with the increase in the tissue and stabilizes after, at 
577MPa. When compared to the modulus of the tissue after total regeneration, it is 
approximately 1.5 times higher.  
The stiffness of the set is shown in Figure 29. Employing the semi-degradable 
scaffold, the set does not exhibit significant drops in its stiffness. This behaviour is 
preferred over the slightly more irregular evolution shown with the degradable 
scaffold. However, the values of stiffness using the semi-degradable scaffold are 
considerably higher than of a healthy Achilles tendon, hence becoming susceptible 
to stress-shielding. 
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Figure 29 - Evolution of the stiffness of the set using the semi-degradable scaffold in the isostress condition 
In Figure 30, the load supported by the regenerating tissue is shown.  
 
Figure 30  - Evolution of the load supported by the regenerating tissue in the isostress condition using the semi-degradable 
scaffold 
The load supported by the tissue has a gradual increase and stabilizes afterwards. In 
this case, after the degradation of PDS and PLGA the amount of load that the tissue 
must bear is much lower than in the scenario using the degradable scaffold. By having 
PTFE as a permanent reinforcement, the load is divided between PTFE and the tissue, 
leaving the tissue to withstand only 55% of the total load. The load supported by the 
scaffold and the tissue is shown in Figure 31.  
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Figure 31 - Evolution of the load supported by the regenerating tissue and the semi-degradable scaffold in the isostress 
condition 
In Figure 32, the strain of the set is shown.  
 
Figure 32 - Evolution of the strain of the set using the semi-degradable scaffold in the isostress condition 
When compared to the strain of the set using the degradable scaffold, this set 
displays approximately half of the peak strain with 4% at approximately 750h, then 
stabilizing at 2.5% after the tissue regenerates completely. As expected an inverse 
proportionality is clear between the stiffness and strain of the set. 
• Isostrain 
As said earlier, when in the isostrain condition, the reinforcement of the scaffold has 
no effect on the load supported by the regenerating tissue, therefore the load 
supported by the regenerating tissue is equal as with the degradable scaffold, as can 
be seen in Figure 33. 
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Figure 33 - Evolution of the load supported by the regenerating tissue and the semi-degradable scaffold 
In Figure 34, the load supported by the set is shown. As can be seen, there is a 
considerable increase in the load provoked by the strain. This is a result of the 
increase both of cross-section area and the Young’s Modulus of the regenerating 
tissue.  
 
Figure 34 - Evolution of the load supported by the set using the semi-degradable scaffold in the isostrain condition 
Being this a simplified model, the results obtained cannot describe real, in vivo 
conditions. However, it is possible to state that the scaffolds presented adequate 
mechanical behaviour during degradation under the simulation conditions. The 
devices provided support to the regenerating tissue in the earlier stages, preventing 
early rupture, then degrading gradually and transferring the load to the tissue. In 
the case of the degradable scaffold, the rupture of the device occurred properly i.e. 
it lost its properties when the mechanical properties of the regenerating tissue 
already permitted full load withstanding, without rupturing. 
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This suitable behaviour is a result of the polymers used to compose the scaffold and 
the respective volume fractions. Therefore, the compositions of the degradable and 
semi-degradable scaffold seemed promising for future investigation. It is important 
to mention that the values of the mechanical properties of the polymers were 
withdrawn from the literature and are concerning different fibre diameters. It was 
assumed that changing the fibre diameter to the diameter used in the scaffolds 
(30µm) would not affect the mechanical properties. Presumably, this will not 
happen. In addition to this, the degradation rates of the fibres will also vary when 
using different diameters due to surface area/volume ratio alterations. 
This investigation was also an attempt to better understand the behaviour of the 
tissue and the scaffold while degrading and how transference of load would happen. 
Avoiding the phenom of stress shielding was attempted designing a scaffold with a 
Young’s Modulus proximate to the healthy Achilles tendon tissue, but it was not 
possible to find if stress-shielding would occur or not. Information which could aid in 
predicting if stress-shielding would occur in this case was not found in the literature. 
Much work is yet to be done in this field such as defining and quantifying the growth 
rate of tissues in the presence of a scaffold, the evolution of the properties of the 
scaffold while performing, the properties of the tissue after total regeneration using 
a scaffold and defining the ideal properties of the scaffold each application such as 
cross-section area, tensile strength and Young’s Modulus.  
Both scaffolds, degradable and semi-degradable, performed well. The indicator for 
the performance of the scaffold is the load supported by the regenerating tissue, 
which shows if it ruptured due to overload or not. Another aspect that is important 
to mention is that it was assumed that the properties of the tendon after 
regeneration through scaffolding were the same as after regeneration through a 
suturing surgery. Even though some studies about the mechanical properties of the 
regenerating Achilles tendon in vitro and in animal models were found  and an 
approximation could be made to the human Achilles tendon, it was chosen to utilize 
data regarding the regenerating human Achilles tendon through suturing surgery.  
Differences between the isostrain and isostress condition were noticeable on 
obtained results. The independence of the loads supported between fibres in the 
isostrain condition was evident by comparing the loads supported by the tissue when 
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using the degradable and the semi-degradable scaffold. The scaffolds had different 
evolutions in their modulus, but the evolution of the load supported by the tissue 
was identical.  
In theory, the semi-degradable scaffold would be more advantageous due to its 
continued support to the weaker tissue. However, the use of non-degradable 
polymers in ligament and tendon grafts has shown many disadvantages including the 
presence of wear debris, loss of mechanical properties, stress-shielding and more. 
Therefore, the application of semi-degradable scaffolds, could be a promising 
solution but only if the limitations of the employment of non-degradable polymers 
in artificial ligaments and tendons were solved.  
7. Model limitations  
The limitations of this model reside on the simplifications which were employed to 
perform the simulation and the design. Mimicking the behaviour of materials in vivo 
and the growth and healing of a ligament or tendon is always very complex, due to 
the number of variables on which the healing process depends and to the in vivo 
environment. These simplifications include assumptions which had to be made to 
perform the simulation and approximations due to lack of information and data.  
Regarding the design of the scaffold, these include, the structure of the scaffold, 
the material properties and their degradation in materials and the mechanical 
behaviour of the materials. The structure of the scaffold utilized in this work 
consisted on parallel fibres with no voids between fibres. This architecture was 
chosen to simplify the algorithmic procedure used in the simulation. The scaffolds 
have many requirements about their structure such as high porosity and high surface 
to volume ratio which were not considered in model.  Another characteristic that 
was assumed to simplify calculations is that the elements exhibit a linear elastic 
behaviour. This is a simplification, as polymers and the tendinous tissue display 
viscoelastic behaviour. Another limitation is the suitability of the data chosen to 
represent the properties of the elements. The mechanical properties were gathered 
from literature, in different degradation media and their evolution was obtained by 
extrapolation and interpolation. The degradation studies of all the materials used 
were performed in vitro and not in vivo which also affects the accuracy of the data 
used for this application. Also, regarding the degradation of the fibres, it was 
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assumed that all the fibres experience degradation equally. In vivo this is not likely 
to occur as polymeric fibres exhibit variations in their properties from fibre to fibre 
and not all the fibres in the scaffold have equal exposure to the degradation medium. 
In the simulation there are some limitations as well. Firstly, in the obtention of the 
data. Like in the materials, the growth of the tendon and its mechanical properties 
are an approximation to reality. The functions which represent the evolution of the 
mechanical properties of the regenerating tissue were obtained also by an 
extrapolation of data from another study, with low data volume. This limits the 
ability of the function to approximate itself from the reality. This lack or low volume 
of data to extrapolate from is especially critical in the case of the tensile strength 
of the regenerating tissue where assumptions had to be made in order to model its 
evolution based on two points. Furthermore, the study used to represent the 
mechanical evolution of the regenerating tissue regards Achilles tendon ruptures 
which were repaired by suturing the ends of the tendon. The healing process in this 
case is surely different than using a scaffold for tendon repair. While the suturing of 
the tendon leads to scarring of the tissue, the use of a scaffold induces a process 
which relies more on tissue growth rather than scarring. This impacts the 
characteristics of the tendon such as its morphology and mechanical properties. 
Another limitation in this simulation are the efforts endured by the tendon and the 
materials. In the simulation performed in this investigation, materials and tendon 
undergo constant stress and strain to study its behaviour during the degradation of 
the polymers and the growth of the tendon. This does not correspond to reality where 
the tendons are subjected to cyclic efforts. All these simplifications and assumptions 
affected the results obtained. By simplifying the design of the scaffold to parallel 
fibres only with no voids or porosity, a difference in the mechanical properties is 
obtained. In the simulation, it is assumed that the cross-section area of the scaffold 
is entirely composed by material, which is not what happens when using fibrous 
scaffolds. Fibrous scaffolds generally exhibit high porosity, which results in lower 
mechanical properties when compared to low or zero porosity structures. In addition 
to this, functional Achilles tendon scaffolds for application in vivo are generally 
utilized in the form of knitted or braided structures, rather than parallel fibres. This 
also affects the mechanical properties of the scaffold, because changing the 
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structure results in a variation of the stiffness, tensile strength and maximum 
elongation of the scaffold, due to each structure having its characteristics. 
Regarding the simplification that both, the polymers and the regenerating tissue, 
exhibit a linear elastic behaviour rather than a viscoelastic behaviour, impact the 
results since in the simulation isostrain and isostress conditions were applied. If the 
viscoelastic properties of the elements would have been considered, the constant 
stress applied to the elements would not result in a constant strain of the elements 
but in a strain, which would vary with time. The same case applies to the isostrain 
condition, where the constant strain applied would result in a varying stress 
depending on time in the elements.  
Concerning the use of material degradation studies in in vitro conditions, this affects 
results by obtaining lower material degradation rates than in in vivo conditions. In 
vivo conditions involve the presence of enzymes, which increase polymer 
degradation. This increase depends on the degree to which polymers suffer 
enzymatic degradation. As PLGA and PDS are not affected greatly by enzymatic 
activity, a large increase would not be expected. As for PLA-PCL, both polymers show 
higher degradation rates in the presence of certain enzymes, therefore a faster 
degradation could occur. 
In relation to the data regarding the regeneration of the Achilles tendon being from 
studies where the tendon was repaired by suturing the tendon rather than being 
treated with the use of a scaffold, the healing process differ as said previously, and 
based on the study in a rabbit model from Moshiri et al. [151], the mechanical 
properties of the tendon should recover at a higher rate and reach higher values 
when treated with scaffolds than when treated with a simple suture of both ends of 
the tendon. 
Lastly, the evolution of the mechanical properties of the materials and regenerating 
tissue were obtained through extrapolation and interpolation using a low amount of 
data, which may impact the accuracy of the functions obtained.  
 
66 
 
8. Conclusions 
Despite being a simplified model, this work allowed the attainment of some insight 
regarding the mechanical behaviour of a scaffold and the regenerating tissue during 
healing of an Achilles tendon rupture. More specifically, it permitted the study of 
the degradation of a scaffold at the same time as the regeneration of the Achilles 
tendon tissue and in what manner the transference of the load could occur. In this 
simulation, the designed scaffolds proved to be suitable, in the mechanical aspect, 
for use in an Achilles tendon rupture site. However, much research needs to be done 
to confirm if these scaffold compositions are appropriate for scaffolding in real, in 
vivo conditions. 
The hypothesis of the employment of a semi-degradable scaffold was proposed, due 
to the low mechanical properties exhibited by the tendon after full regeneration.  
However, the increase in cross-section area observed in the fully regenerated tendon 
appears to balance the low mechanical properties of the tissue by maintaining the 
stiffness and maximum load at values not too far from a healthy tendon. This suggests 
that using a non-degradable portion to reinforce the tendon permanently may not be 
necessary. Further research must be done to confirm the validity of this assertion. 
Much work is yet to be done in the field of tissue engineering, particularly on the 
mechanical aspects, such as defining the mechanical properties of the Achilles 
tendon after full healing of a total rupture and studying the evolution of those 
mechanical properties during regeneration. For instance, data regarding the 
breaking tensile strength of tendons after rupture was not found in the literature. 
Another important aspect to be studied is the treatment of this injury using tissue 
engineering scaffolds and the effect of these devices on the mechanical properties 
of the regenerating tendon.  
Following this work, more accurate simulations can be performed. This can be 
accomplished by using a fibrous structure suitable for scaffolding combined with 
Finite Element Method in the simulation. This would also be achieved if the 
degradation tests are performed at similar conditions to the in vivo environment. 
Filling the gaps of information detected during this investigation, would also avoid 
some a priori simplifications and assumptions. 
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Annex A – Regression models used to obtain the mechanical properties of 
materials 
 
Figure 1 - Regression model used for the Tensile strength of PLGA 
 
Figure 2 - Regression model used for the Young's Modulus of PLGA 
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Figure 335 - Regression model used for the Young's Modulus of PLA-PCL 
 
Figure 4 - Regression model used for the Tensile strength of PDS 
 
Figure 5 - Regression model used for the Young's Modulus of PDS 
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Annex B – Diagram of the procedure used in the simulations in the Isostrain 
and Isostress conditions 
 
Figure 1 - Diagram illustrating the algorithmic procedure followed in the isostrain condition 
 
Calculate the parameters of the set
Calculate parameters for the scaffold
If yes, the load sustained, Young's Modulus and cross-
section area of the material/tissue are zeroed
Check if the load sustained by each material and tissue is 
higher than their failure load 
Calculate the load sustained by the materials and tissue
Determine the time-dependent properties of the materials 
and tissue
For each time step tn
Input time dependent functions (obtained through 
modelling)
Isostrain
Set time independent parameters e0 and A0i
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Figure 2 - Diagram illustrating the algorithmic procedure followed in the isostress condition 
Calculate the remaining parameters of the set
Calculate parameters of the scaffold
If yes, the load sustained, Young's Modulus and cross-
section area of the material or tissue are zeroed.
Check if load sustained by each material and tissue exceeds 
failure load 
Calculate the remaining time dependent parameters of the 
materials and tissue
Calculate strain of the set (ε)
Determine the Pmax and EA of the materials and tissue
For each time step tn
Input time-dependent functions (obtained through 
modelling)
Isostress
Set time independent properties P0, A0i
